<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Multiple Choice Question Preparation</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <style>
    :root {
      --bg: #f8f9fb;
      --fg: #222;
      --card: #fff;
      --accent: #007bff;
      --error: #dc3545;
      --correct: #28a745;
      --border: #e5e7eb;
      --progress: #007bff;
      --progress-bg: #e9ecef;
      --outline-correct: #28a745;
      --outline-wrong: #dc3545;
      --btn-secondary-bg: #6c757d;
      --btn-secondary-fg: #fff;
    }
    body.dark {
      --bg: #18191a;
      --fg: #e4e6eb;
      --card: #242526;
      --accent: #4f8cff;
      --border: #3a3b3c;
      --progress-bg: #3a3b3c;
      --btn-secondary-bg: #4a4a4a;
      --btn-secondary-fg: #e4e6eb;
    }
    body {
      background: var(--bg);
      color: var(--fg);
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
      margin: 0;
      min-height: 100vh;
    }
    .container {
      max-width: 800px;
      margin: 20px auto;
      background: var(--card);
      border-radius: 12px;
      box-shadow: 0 4px 16px rgba(0,0,0,0.08);
      padding: 24px;
    }
    h1, h2, h3 {
      margin-top: 0;
      font-weight: 700;
    }
    button, input[type="file"], select, input[type="submit"] {
      background: var(--accent);
      color: #fff;
      border: none;
      padding: 10px 18px;
      border-radius: 6px;
      font-size: 1em;
      cursor: pointer;
      margin: 6px 4px 6px 0;
      outline: none;
      transition: background 0.15s;
      font-weight: 500;
    }
    button:hover, input[type="submit"]:hover {
      opacity: 0.9;
    }
    button[disabled] {
      opacity: 0.5;
      pointer-events: none;
    }
    .btn-secondary {
      background: var(--btn-secondary-bg);
      color: var(--btn-secondary-fg);
    }
    .btn-danger {
      background: var(--error);
    }
    .global-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 24px;
      flex-wrap: wrap;
    }
    .header-icons {
      display: flex;
      align-items: center;
      gap: 8px;
    }
    .icon-btn {
      font-size: 1.5em;
      background: none;
      border: none;
      color: var(--fg);
      cursor: pointer;
      padding: 5px;
    }
    .main-menu {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
      gap: 16px;
      margin-top: 24px;
    }
    .menu-button {
      background: var(--bg);
      border: 1.5px solid var(--border);
      padding: 20px;
      text-align: center;
      font-size: 1.2em;
      font-weight: 600;
      border-radius: 10px;
      cursor: pointer;
      transition: transform 0.2s, box-shadow 0.2s;
    }
    .menu-button:hover {
      transform: translateY(-3px);
      box-shadow: 0 4px 12px rgba(0,0,0,0.1);
      border-color: var(--accent);
    }
    .notes-section {
      margin-top: 48px;
      padding-top: 24px;
      border-top: 1px solid var(--border);
      font-size: 0.9em;
      color: #6c757d;
    }
    body.dark .notes-section {
      color: #aaa;
    }
    .notes-section p { margin: 8px 0; }
    .question-card {
      background: var(--card);
      border: 1.5px solid var(--border);
      border-radius: 10px;
      padding: 20px;
      margin-bottom: 16px;
    }
    .question-img {
      max-width: 100%;
      max-height: 250px;
      display: block;
      margin: 10px 0;
      border-radius: 8px;
    }
    .responses {
      display: flex;
      flex-direction: column;
      gap: 10px;
      margin-top: 15px;
    }
    .response-box {
      border: 1.5px solid var(--border);
      border-radius: 8px;
      padding: 12px 16px;
      font-size: 1.05em;
      cursor: pointer;
      user-select: none;
      transition: border 0.2s, background 0.2s;
      display: flex;
      align-items: center;
      gap: 12px;
    }
    .response-prefix {
      font-weight: bold;
      color: var(--accent);
    }
    .response-box.correct {
      border: 2px solid var(--outline-correct);
      background: rgba(40, 167, 69, 0.1);
    }
    .response-box.correct .response-prefix {
      color: var(--outline-correct);
    }
    .response-box.wrong {
      border: 2px solid var(--outline-wrong);
      background: rgba(220, 53, 69, 0.1);
    }
    .response-box.wrong .response-prefix {
      color: var(--outline-wrong);
    }
    .progress-bar-wrap {
      height: 16px;
      background: var(--progress-bg);
      border-radius: 8px;
      overflow: hidden;
      margin-bottom: 12px;
      margin-top: 6px;
    }
    .progress-bar {
      background: var(--progress);
      height: 100%;
      width: 0;
      transition: width 0.3s;
    }
    .score-bar {
      margin-top: 18px;
      font-size: 1.5em;
      font-weight: bold;
      text-align: center;
    }
    .score-remark {
      text-align: center;
      margin-top: 10px;
      font-style: italic;
      font-size: 1.2em;
      padding: 10px;
      border-radius: 6px;
      background: var(--bg);
    }
    .setup-form {
        border: 1.5px solid var(--border);
        padding: 20px;
        border-radius: 10px;
        margin-top: 20px;
    }
    .form-group {
        margin-bottom: 15px;
    }
    .form-group label {
        display: block;
        margin-bottom: 5px;
        font-weight: 500;
    }
    input[type="text"], input[type="number"], textarea {
      width: 100%;
      padding: 9px;
      margin: 4px 0 10px 0;
      border: 1.5px solid var(--border);
      border-radius: 6px;
      font-size: 1em;
      background: var(--bg);
      color: var(--fg);
      outline: none;
      box-sizing: border-box;
    }
    .range-input {
        display: flex;
        gap: 10px;
        align-items: center;
    }
    .range-input input {
        width: 100px;
    }
    .instruction-page p {
      line-height: 1.6;
      margin-bottom: 1em;
    }
    .instruction-page h3 {
      margin-top: 1.5em;
    }
    @media(max-width: 700px) {
      .container { padding: 18px 4vw; }
      .main-menu { grid-template-columns: 1fr; }
    }
  </style>
</head>
<body>

<audio id="bg-music" loop></audio>
<div class="container" id="app"></div>

<script>
// --- Data structure, Keys, and Constants ---
const MAIN_BANK_KEY = "mcq_main_bank_v4";
const MEMORY_LIST_KEY = "mcq_memory_list_v4";
const SETTINGS_KEY = "mcq_settings_v4";

// IMPORTANT: Replace this placeholder with your own Base64 music string
const musicBase64 = "data:audio/mpeg;base64,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";

// --- State Management ---
function getDefaultState() {
  return {
    view: "menu",
    mainQuestionBank: [
       {
    question: "Les Anti-Herpétique: cocher une réponse fausse",
    img: "",
    responses: [
      "Aciclovir",
      "Valaciclovir",
      "Famciclovir",
      "ZOVIRAX",
      "Ténofovir"
    ],
    correct: 4
  },
  {
    question: "Les anti-CMV: cocher une réponse fausse",
    img: "",
    responses: [
      "Ganciclovir",
      "Valganciclovir",
      "Cidofovir",
      "CYMEVAN",
      "Entécavir"
    ],
    correct: 4
  },
  {
    question: "Les anti-grippaux: cocher une réponse vraie",
    img: "",
    responses: [
      "ZOVIRAX",
      "ZELITREX",
      "ORAVIR",
      "Valaciclovir",
      "TAMINFLU"
    ],
    correct: 4
  },
  {
    question: "Les médicaments anti-Hépatite B: cocher une réponse fausse",
    img: "",
    responses: [
      "Lamivudine",
      "Adéfovir",
      "Ténofovir",
      "3TC",
      "Abacavir"
    ],
    correct: 4
  },
  {
    question: "Les médicaments anti-Hépatite B (médicament injectable): cocher une réponse vraie",
    img: "",
    responses: [
      "Lamivudine",
      "Adéfovir",
      "Ténofovir",
      "3TC",
      "Interféron"
    ],
    correct: 4
  },
  {
    question: "Les médicaments anti-Hépatite B (médicament premier choix): cocher une réponse vraie",
    img: "",
    responses: [
      "Lamivudine",
      "Adéfovir",
      "Ténofovir",
      "3TC",
      "Telbivudine"
    ],
    correct: 2
  },
  {
    question: "Les médicaments anti-Hépatite B: cocher une réponse fausse",
    img: "",
    responses: [
      "ZEFFIX",
      "3TC",
      "D4T",
      "EPIVIR",
      "Lamivudine"
    ],
    correct: 2
  },
  {
    question: "Les médicaments anti-Hépatite C: cocher une réponse fausse",
    img: "",
    responses: [
      "Copegus",
      "Ribavirine",
      "Entecavir",
      "Vilona",
      "Rebetol"
    ],
    correct: 2
  },
  {
    question: "Les médicaments pur traiter l'hépatite C: cocher une réponse fausse",
    img: "",
    responses: [
      "Copegus + Entécavir",
      "Ribavirine + IFN",
      "Daclastasvir + Sofosbuvir",
      "Vilona + Peg IFN",
      "Rebetol + Sofosbuvir"
    ],
    correct: 0
  },
  {
    question: "Les médicaments anti-Hépatite C (DAA): cocher une réponse fausse",
    img: "",
    responses: [
      "Sofosbuvir",
      "Ladipasvir",
      "PEG IFN Alpha",
      "Daclastavir",
      "HARVONI"
    ],
    correct: 2
  },
  {
    question: "Les anti-parasitaires: cocher une réponse fausse",
    img: "",
    responses: [
      "Anti paludéen",
      "Anti amibienne",
      "Antihelminthique",
      "Antiprotozoaire",
      "Anti mycosique"
    ],
    correct: 4
  },
  {
    question: "Les anti-paludéens: cocher une réponse fausse",
    img: "",
    responses: [
      "Chloroquine",
      "Méfloquine",
      "Artésunate",
      "Artéméther",
      "Quinolone"
    ],
    correct: 4
  },
  {
    question: "Les anti-amibienne: cocher une réponse vraie",
    img: "",
    responses: [
      "Métronidazole",
      "Quinine",
      "Quinidine",
      "Doxycycline",
      "Chloroquine"
    ],
    correct: 0
  },
  {
    question: "Métronidazole pour traiter cocher une réponse fausse",
    img: "",
    responses: [
      "Abcès hépatique",
      "Sd dysentérie",
      "Amoebome",
      "Trichomonas",
      "Traitement HBV"
    ],
    correct: 4
  },
  {
    question: "Les anti helminthiques: cocher une réponse fausse",
    img: "",
    responses: [
      "Albendazole",
      "Mébendazole",
      "Ivermectine",
      "Stromectol",
      "Tinidazole"
    ],
    correct: 4
  },
  {
    question: "What is the recommended standard treatment duration for leprosy?",
    img: "",
    responses: [
      "6 months for children and 12 months for adults",
      "1 or 2 months depending on the operational or clinical classification of the disease",
      "6 or 8 months depending on the operational or clinical classification of the disease",
      "6 or 12 months depending on the operational or clinical classification of the disease",
      "12 or 18 months depending on the operational or clinical classification of the disease"
    ],
    correct: 3
  },
  {
    question: "WHO regime for paucibacillary leprosy (PB) in adult is:",
    img: "",
    responses: [
      "50mg Dapsone daily + 450mg Rifampien monthly",
      "100mg Dapsone daily + 600mg Rifampien daily",
      "300mg Clofazimine daily + 300mg Rifampcin daily",
      "100mg Dapsone daily + 600mg Rifampicin monthly",
      "100mg Dapsone + 600mg Rifampcin + 300mg Clofazimine daily"
    ],
    correct: 3
  },
  {
    question: "Dose of Rifampicin recommended in multibacillary leprosy in adult is 600 mg",
    img: "",
    responses: [
      "Once daily",
      "Once in a week",
      "Twice weekly",
      "Once in a month",
      "Twice monthly"
    ],
    correct: 3
  },
  {
    question: "What is the Mechanism of action of Dapsone against Mycobacterium leprae?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibition of dihydropteroate synthase",
      "Inhibition of neutrophil and eosinophil myeloperoxidase",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 1
  },
  {
    question: "Which statement is true about pharmacokinetic of Dapsone?",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Absorption from the gut is variable.",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 4
  },
  {
    question: "Which statement is true about pharmacokinetic of Dapsone?",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Excretion into bile and urine",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Cross the placenta, and is found in human breast milk"
    ],
    correct: 4
  },
  {
    question: "What is the common adverse reactions of Dapsone?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic",
      "Methemoglobinemia",
      "Hyperuricemia may provoke acute gouty arthritis",
      "Harmless orange color to urine, sweats, tears, and contact lenses",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness"
    ],
    correct: 1
  },
  {
    question: "What is the Mechanism of action of Rifampicin against Mycobacterium leprae?",
    img: "",
    responses: [
      "Inhibition of dihydropteroate synthase",
      "Inhibits mycobacterial arabinosyltransferases",
      "Inhibition of neutrophil and eosinophil myeloperoxidase",
      "Inhibits bacterial DNA-dependent RNA synthesis",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 3
  },
  {
    question: "Which statement is true about pharmacokinetic of Rifampicin?",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Excreted in the feces, small amount in the urine",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 1
  },
  {
    question: "What is the most common adverse reactions of Rifampicin?",
    img: "",
    responses: [
      "Methemoglobinemia is common",
      "Gastrointestinal intolerance occurs occasionally",
      "Loss of visual acuity and red-green color blindness",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Harmless orange color to urine, sweats, tears, and contact lenses"
    ],
    correct: 4
  },
  {
    question: "What is the common adverse reactions of Rifampicin?",
    img: "",
    responses: [
      "Erythema nodosumleprosum",
      "Flu-like syndrome and thrombocytopenia",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Hyperuricemia may provoke acute gouty arthritis",
      "Skin discoloration ranging from red-brown to nearly black"
    ],
    correct: 1
  },
  {
    question: "Which statement is the mechanism of actionof Clofazimine?",
    img: "",
    responses: [
      "Inhibition of RNA synthesis.",
      "Inhibition of dihydropteroate synthase",
      "Inhibition of mycobacterial arabinosyltransferases",
      "Inhibition of neutrophil and eosinophil myeloperoxidase",
      "Inhibition of mycobacterial growth and binds preferentially to mycobacterial DNA"
    ],
    correct: 4
  },
  {
    question: "Which statement is true about pharmacokinetic of Clofazimine?",
    img: "",
    responses: [
      "Excreted in urine",
      "Cross the blood-brain barrier",
      "Excreted in the feces, small amount in the urine",
      "Half-life is variable, with values as long as 70 days.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 3
  },
  {
    question: "Which statement is true about pharmacokinetic of Clofazimine?",
    img: "",
    responses: [
      "Half-life may be 2 months",
      "Metabolism: not known",
      "Cross the blood-brain barrier",
      "Cross the placenta, and is found in human breast milk",
      "Skin heavily infected with M leprae may contain several times more drug than normal skin"
    ],
    correct: 3
  },
  {
    question: "Which statement is the adverse reaction of Clofazimine?",
    img: "",
    responses: [
      "Erythema nodosumleprosum",
      "Gastrointestinal intolerance, fever, pruritus.",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Skin discoloration ranging from pink to brownish-black",
      "Methemoglobinemia is common, but usually is not a problem clinically"
    ],
    correct: 3
  },
  {
    question: "Which statement is the adverse reaction of Clofazimine?",
    img: "",
    responses: [
      "Ichthyosis and dryness",
      "Erythema nodosumleprosum",
      "Gastrointestinal intolerance, fever, pruritus.",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Methemoglobinemia is common, but usually is not a problem clinically"
    ],
    correct: 0
  },
  {
    question: "A young female patient using an oral contraceptive is to be treated for leprosy. She is advised to use an additional method of contraception since the efficacy of the oral agents is commonly decreased if her drug regimen includes:",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Ofloxacin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"orange colors to urine, sweat, tears, and contact lenses\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Ofloxacin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has \"Erythema nodosum leprosum\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"Flu-like syndrome and thrombocytopenia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"Ichthyosis and dryness\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has \"hemolytic anemia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"Blurred vision, paraesthesia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "Which of the following drugs may cause \"risk of postnatal haemorrhage\"?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 1
  },
  {
    question: "Skin pigmentation and icthyosis like side effects are seen in patient who received:",
    img: "",
    responses: [
      "Rifampcin",
      "Clofazimine",
      "Dapsone",
      "Steroid",
      "Thalidomide"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he come back because his skin is dusty, his tongue and lips are blue. He has headache and also tired because of you. His SaO2 is low. Which is the following drugs my cause this side effects?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "What is the Mechanism of Action of INH against M tuberculosis?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 1
  },
  {
    question: "What is the most common adverse reactions of INH?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "The risk of peripheral neuropathy",
      "Flu-like syndrome and thrombocytopenia",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness."
    ],
    correct: 1
  },
  {
    question: "Isoniazid may cause peripheral neuropathy and anaemia as its side effects because",
    img: "",
    responses: [
      "It is toxic to nerves and to red blood cells.",
      "It is a type of hypersensitivity reaction.",
      "It prevents absorption of iron and ascorbic acid.",
      "It interferes with pyridoxine metabolism and induces its deficiency."
    ],
    correct: 3
  },
  {
    question: "What is the Mechanism of action Rifampicin against TB?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 0
  },
  {
    question: "What is the Mechanism of action EMB against TB?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the $12 ribosomal subunit."
    ],
    correct: 2
  },
  {
    question: "What is the most common adverse reactions of EMB?",
    img: "",
    responses: [
      "Acute gouty arthritis.",
      "Ototoxic and Nephrotoxic.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 3
  },
  {
    question: "What is the most common adverse reactions of PZA?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 1
  },
  {
    question: "A young female patient using an oral contraceptive is to be treated for pulmonary tuberculosis. She is advised to use an additional method of contraception since the efficacy of the oral agents is commonly decreased if her drug regimen includes:",
    img: "",
    responses: [
      "Streptomycin",
      "Ethambutol",
      "Isoniazid",
      "Pyrazinamide",
      "Rifampicin"
    ],
    correct: 4
  },
  {
    question: "What is the most common toxicity of streptomycin?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Rashes, thrombocytopenia, and nephritis.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Immunologic Reactions, Hepatitis and Peripheral neuropathy."
    ],
    correct: 0
  },
  {
    question: "Which of the following drugs, inhibits mycobacterial arabinosyl transferases?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has an symptoms as \"peripheral neuropathy. Which one of the following medicines can cause this adverse reaction?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as \"orange colors to urine, sweat, tears, and contact lenses\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as \"arthralgia with biological sign of Hyperuricemia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 3
  },
  {
    question: "The primary reason for the use of drug combinations in the treatment of tuberculosis is to:",
    img: "",
    responses: [
      "Reduce the incidence of adverse effects.",
      "Delay or prevent the emergence of resistance.",
      "Ensure patient compliance with the drug regimen.",
      "Provide prophylaxis against other bacterial infections.",
      "Enhance activity against metabolically inactive mycobacteria."
    ],
    correct: 1
  },
  {
    question: "Pyridoxine is given to a patient of tuberculosis prevents",
    img: "",
    responses: [
      "INH induced peripheral neuritis",
      "Rifampicin induced hepatotoxicity",
      "Ethambutol induced visual defects",
      "Pyrazinamide induced neurotoxicity",
      "Streptomycin induced nephrotoxicity"
    ],
    correct: 0
  },
  {
    question: "What is the Mechanism of Action of Isoniazid against M tuberculosis? Choose one best answer.",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 1
  },
  {
    question: "What is the most common adverse reactions of Isoniazid? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "The risk of peripheral neuropathy",
      "Flu-like syndrome and thrombocytopenia",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness."
    ],
    correct: 1
  },
  {
    question: "Isoniazid may cause peripheral neuropathy and anaemia as its side effects because",
    img: "",
    responses: [
      "It is toxic to nerves and to red blood cells.",
      "It is a type of hypersensitivity reaction.",
      "It prevents absorption of iron and ascorbic acid.",
      "It interferes with pyridoxine metabolism and induces its deficiency."
    ],
    correct: 3
  },
  {
    question: "What is the Mechanism of action Rifampicin against TB? Choose one best answer.",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 0
  },
  {
    question: "What is the most common adverse reactions of Rifampicin? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Lupus-like syndrome, pellagra, arthralgia",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 2
  },
  {
    question: "What is the Mechanism of action Ethambutol against TB? Choose one best answer.",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 2
  },
  {
    question: "What is the most common adverse reactions of Ethambutol? Choose one best answer.",
    img: "",
    responses: [
      "Acute gouty arthritis.",
      "Ototoxic and Nephrotoxic.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 3
  },
  {
    question: "Which statement is true about Pharmacokinetics of Pyrazinamide? Choose one best answer.",
    img: "",
    responses: [
      "Half-life: 3-4 h, metabolized by the liver, about 20% is excreted unchanged in the feces.",
      "Half-life: 3-5 h, metabolized by the liver, about 20% is excreted unchanged in the feces.",
      "Half-life: 8-11h, metabolized by the liver, excreted in the urine.",
      "Half-life: 8-11h, not metabolized in the body and eliminate with active form."
    ],
    correct: 2
  },
  {
    question: "What is the most common adverse reactions of Pyrazinamide? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 1
  },
  {
    question: "A young female patient using an oral contraceptive is to be treated for pulmonary tuberculosis. She is advised to use an additional method of contraception since the efficacy of the oral agents is commonly decreased if her drug regimen includes",
    img: "",
    responses: [
      "Streptomycin",
      "Ethambutol",
      "Isoniazid",
      "Pyrazinamide",
      "Rifampicin"
    ],
    correct: 4
  },
  {
    question: "What is the most common toxicity of Streptomycin? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Rashes, thrombocytopenia, and nephritis.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Immunologic Reactions, Hepatitis and Peripheral neuropathy."
    ],
    correct: 0
  },
  {
    question: "Which of the following drugs, inhibits mycobacterial arabinosyl transferases? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has a symptom as “peripheral neuropathy. Which one of the following medicines can cause this adverse reaction? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as “orange colors to urine, sweat, tears, and contact lenses”. Which one of the following medicine can cause this adverse reaction? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as “arthralgia with biological sign of Hyperuricemia”. Which one of the following medicine can cause this adverse reaction? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 3
  },
  {
    question: "The primary reason for the use of drug combinations in the treatment of tuberculosis is to",
    img: "",
    responses: [
      "Reduce the incidence of adverse effects.",
      "Delay or prevent the emergence of resistance.",
      "Ensure patient compliance with the drug regimen.",
      "Provide prophylaxis against other bacterial infections.",
      "Enhance activity against metabolically inactive mycobacteria."
    ],
    correct: 1
  },
  {
    question: "Pyridoxine is given to a patient of tuberculosis prevents",
    img: "",
    responses: [
      "INH induced peripheral neuritis",
      "Rifampicin induced hepatotoxicity",
      "Ethambutol induced visual defects",
      "Pyrazinamide induced neurotoxicity",
      "Streptomycin induced nephrotoxicity"
    ],
    correct: 0
  },
  {
    question: "What is the recommended standard treatment duration for leprosy?",
    img: "",
    responses: [
      "6 months for children and 12 months for adults",
      "1 or 2 months depending on the operational or clinical classification of the disease",
      "6 or 8 months depending on the operational or clinical classification of the disease",
      "6 or 12 months depending on the operational or clinical classification of the disease",
      "12 or 18 months depending on the operational or clinical classification of the disease"
    ],
    correct: 3
  },
  {
    question: "WHO regime for paucibacillary leprosy (PB) in adult is:",
    img: "",
    responses: [
      "50mg Dapsone daily + 450mg Rifampicn monthly",
      "100mg Dapsone daily + 600mg Rifampicn daily",
      "300mg Clofazimine daily + 300mg Rifampcin daily",
      "100mg Dapsone daily + 600mg Rifampicin monthly",
      "100mg Dapsone + 600mg Rifampcin + 300mg Clofazimine daily"
    ],
    correct: 3
  },
  {
    question: "Which statement is true about pharmacokinetic of Dapsone? Choose one best answer.",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Absorption from the gut is variable.",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 4
  },
  {
    question: "Which statement is “correct” about adverse reactions of Dapsone? Choose one best answer.",
    img: "",
    responses: [
      "Methemoglobinemia is common.",
      "Gastrointestinal intolerance occurs occasionally.",
      "Loss of visual acuity and red-green color blindness.",
      "Skin discoloration ranging from red-brown to nearly black.",
      "It may cause cholestatic jaundiceand occasionally hepatitis"
    ],
    correct: 0
  },
  {
    question: "Dose of rifampicin recommended in multibacillary leprosy in adult is 600 mg",
    img: "",
    responses: [
      "Once daily",
      "Once in a week",
      "Twice weekly",
      "Once in a month",
      "Twice monthly"
    ],
    correct: 3
  },
  {
    question: "Which statement is the adverse reaction of Clofazimine? Choose one best answer.",
    img: "",
    responses: [
      "Gastrointestinal intolerance, fever, pruritus.",
      "Erythema nodosumleprosum often develops.",
      "Skin discoloration ranging from pink to brownish-black.",
      "Hemolysis, particularly if they have G6PD deficiency.",
      "Methemoglobinemia is common, but usually is not a problem clinically."
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he come back with his lawyer because his skin is dusty, his tongue and lips are blue...and he threatens to sue....He has headache and also tired because of you. His SaO2 is low. Which one of the following drugs can cause this adverse reaction?",
    img: "",
    responses: [
      "Rifampcin",
      "Clofazimine",
      "Dapsone",
      "Steroid",
      "Thalidomide"
    ],
    correct: 2
  },
  {
    question: "Definition de la pharmacodépendance ? (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "L’étude des effets des médicaments",
      "L’étude des effets indésirables des médicaments",
      "La répétition de l’utilisation des Canabis",
      "L’impossibilité pour un organisme de fonctionner correctement sans le médicament auquel il s’est accoutumé",
      "L’étude de passage de médicament dans l’organisme"
    ],
    correct: 3
  },
  {
    question: "Les substances qui provoquent la toxicomanie sont classé en (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "2 groupes",
      "3 groupes",
      "4 groupes",
      "5 groupes",
      "6 groupes"
    ],
    correct: 3
  },
  {
    question: "L’alcool éthylique est classé dans le groupe ( cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "Hallucinogène",
      "Enivrants",
      "Excitants",
      "Tranquilisant",
      "Opiacés"
    ],
    correct: 1
  },
  {
    question: "L’éther est ( cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Classé dans le groupe des énivrants",
      "Pyschostimulant",
      "Produit dopant",
      "Provoque le décharge des catécholamines endogène",
      "est un produit anesthésique"
    ],
    correct: 3
  },
  {
    question: "Pharmacodynamique ? (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "étude des effets secondaires des médicaments",
      "étude du actions de médicament dans l’organisme",
      "étude de métabolisme des médicaments",
      "étude des éliminations des médicaments",
      "étude des fabrication des médicaments"
    ],
    correct: 1
  },
  {
    question: "Les règles de base de la pharmacologie ? (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Posologie",
      "Mode d’administration",
      "Indications clinique",
      "Contre-indication",
      "Etude le prix des médicaments"
    ],
    correct: 4
  },
  {
    question: "Pharmacologie fondamentale ? (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Méthode de biologie moléculaire",
      "Méthode d’expertise toxicologie",
      "Méthode de la physiolic expérimentale",
      "Méthode de la Criblage",
      "L’étude des effets des médicaments chez l’homme"
    ],
    correct: 4
  },
  {
    question: "Fonctions du médicament, (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Préventive individuelle",
      "Préventive collective",
      "Traitement substitutive",
      "Traitement curative",
      "Toxique"
    ],
    correct: 4
  },
  {
    question: "Origine des médicaments (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Origine végétale",
      "Origine animale",
      "Origine synthétique",
      "Origine biogénétique",
      "Origine biologique"
    ],
    correct: 3
  },
  {
    question: "Dénomination des médicaments (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Nom chimique",
      "DCI",
      "Nom de marque",
      "Dénominations Communes Internationales",
      "Nom de médicaments du prix élevé"
    ],
    correct: 4
  },
  {
    question: "Pharmacocinétique de l’éthanol (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "À jeun le pic de concentration atteint en 30mn",
      "L’estomac plein augmente l’absorption",
      "90% oxydé dans le foie, le reste est excrété par le rein et le poumon",
      "L’adulte peur métaboliser 7 à 10g d’alcool par heure",
      "La barrière hémato-encéphalique est très perméable à l’éthanol"
    ],
    correct: 1
  },
  {
    question: "Action sur le système nerveux central suivant, Le taux alcoolémie (g /l) (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "0.5-1 sédation, euphorie",
      "1-2 altération de la motricité",
      "2-3 vomissement, somnolence",
      "5 coma",
      "> 5 dépression respiratioire"
    ],
    correct: 3
  },
  {
    question: "Conséquence d’une consommation chronique de l’alcool sur le foie et tube digestif (cocher 1 réponse fausse)",
    img: "",
    responses: [
      "Stéatose hépatique",
      "Cirrhose du foie",
      "Pancréatite",
      "Oesophagite",
      "Gastrite"
    ],
    correct: 3
  },
  {
    question: "Conséquence d’une consommation chronique de l’alcool sur le système endocrine (cocher 1 réponse fausse)",
    img: "",
    responses: [
      "Gynécomastie",
      "Hyperglycémie",
      "Atrophie musculaire",
      "Hyperaldostéronisme secondaire grave",
      "Trouble de l’équilibre hydro-életrolytique"
    ],
    correct: 1
  },
  {
    question: "Le médicament qui donne effet (Autabuse) (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "Aspirine",
      "Ampicilline",
      "Métronidazole",
      "Laroscorbine",
      "Gentamycine"
    ],
    correct: 2
  },
  {
    question: "Au cours de la grossesse l’abus chronique de l’alcool provoque (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Retard de croissance intra-utérin",
      "Une microcéphalie",
      "Mauvaise coordination motrice",
      "Des anomalies articulaire mineurs",
      "Paralysie des membres"
    ],
    correct: 4
  },
  {
    question: "Abbviation d’un médicament antirétrovirale de Inhibiteur nucléoside de transcriptase inverse, autrefois utilisé comme antivirus de l’hépatite .B (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "D4T",
      "3TC",
      "AZT",
      "DDI",
      "ABC"
    ],
    correct: 0
  },
  {
    question: "Un antirétroviral très utiliser dans le derneir trimeste de grossesse pour éviter la contamination de la mère au nouveau-né (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "Lamivudine",
      "Névirapine (Viramune)",
      "Zidovudine",
      "Abacavir"
    ],
    correct: 2
  },
  {
    question: "Cocher sur l’inhibiteur de protéase",
    img: "",
    responses: [
      "Névirapine",
      "Ritonavir",
      "Stavudine",
      "Lamivudine",
      "Abacavir"
    ],
    correct: 1
  },
  {
    question: "La voie digestive n’est pas toujours utilisable selon la nature du médicament (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Dégradé par le pH acide de l’estomac",
      "Dégradé par les enzymes protéolytiques digestives",
      "Irritant ou caustique pour les muqueuse digestive",
      "Non résorbé",
      "Traitement des pathologies hépatiques"
    ],
    correct: 4
  },
  {
    question: "Utilisation per os pour rechercher une action locale (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Pansement",
      "Anti-hémorrodaïres en suppositoires",
      "Anitparasitaires intestinaux",
      "Anti-spasmodiques",
      "Sufamides intestinaux"
    ],
    correct: 3
  },
  {
    question: "Médicaments per os ont des actions générales (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Résorbtion buccale",
      "Résorbtion gastrique",
      "Les antiparasitaires interstinaux",
      "Résorbtion dans l’intestin grêle",
      "Résorbtion par le gros intestin"
    ],
    correct: 2
  },
  {
    question: "Voie intamusculaire (IM) : (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Glucocorticoïde retartd peut provoquer atrophie musculaire localisée",
      "Phénomènes d’enkystement",
      "Injection des anticoagulants",
      "Moins douleureuse que le voie sous cutanée",
      "Possible de préparation huileuses"
    ],
    correct: 2
  },
  {
    question: "Voie transcutané : (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Résorbtion coustante et régulière",
      "Mauvaise biodisponibilité",
      "La lésion cutanée augmente la résorbtion des médicaments",
      "Les désinfections mercuriels peuvent augmenter la toxicité",
      "L’arrêt immédiat du médicament par simple ablation"
    ],
    correct: 1
  },
  {
    question: "Contre-indications de l’Amphotéricine B (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Insuffisance rénale pré-existance",
      "Réaction de hypersensiblité",
      "Risque d’association dangereuse avec les antiarythmique",
      "La possibilité d’effet tératogène",
      "Hépatite"
    ],
    correct: 4
  },
  {
    question: "Le nom commercial de Kéroconazole (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "Daktarin",
      "Nizoral",
      "Sporanox",
      "Triflucan",
      "Flagyl"
    ],
    correct: 1
  },
  {
    question: "Griséofulvine est antifongique pour traiter (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Candida",
      "Crytococcus",
      "Dermatophyte",
      "Aspergillus",
      "Blastomycose"
    ],
    correct: 2
  },
  {
    question: "L’acide utilisé pour préserver les aliments (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "Acide acétique",
      "Acide benzoïque",
      "Acide chloridrique",
      "Acide borique",
      "Acide lactique"
    ],
    correct: 1
  },
  {
    question: "Les antiseptique et désinfectant de l’eau de boisson (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "Acide acétique",
      "Le permanganate de potassium",
      "Chlorramine",
      "L’acide borique",
      "L’acide lactique"
    ],
    correct: 2
  },
  {
    question: "La posologie des médicaments pour les adultes ? (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "Tenant compte de la taille",
      "Tenant compte du poids",
      "Tenant compte d’élimination par le foie",
      "Tenant compte d’élimination par le rein",
      "Tenant compte du prix"
    ],
    correct: 4
  },
  {
    question: "Adaptation de doses des médicaments chez le sujet âgé (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "À 65 ans 65% de la dose adulte",
      "À 80 ans 50% de la dose adulte",
      "Ou calculera la dose à partir de la clairance de la créatinine",
      "Selon le gravité de la maladie",
      "Selon les capacités d’élimination"
    ],
    correct: 3
  },
  {
    question: "Adaptation de dose chez l’enfant (le nouveau-né): (cocher sur 1 réponse fausse)",
    img: "",
    responses: [
      "L’immaturation enzymatique",
      "Le volume de distribution est différent",
      "La clairance rénale est très faible",
      "Le bilirubine (libre) est très dangereux pour le système nerveux central",
      "La perfusion d’alumine humaine augmente la fraction libre de la bilirubine"
    ],
    correct: 4
  },
  {
    question: "Adaptation de dose chez l’enfant plus de 2 ans (cocher sur 1 réponse juste)",
    img: "",
    responses: [
      "En fonction de pathologie",
      "Règle de trois à partir de calculer la posologie adulte standard du poids",
      "En fonction de la clairance rénale",
      "Selon le sexe",
      "Selon la taille"
    ],
    correct: 1
  },
  {
    question: "Le nom générique ABC",
    img: "",
    responses: [
      "Ténofovir",
      "Stavutine",
      "Abacavir",
      "Didanosine",
      "Lamivudine"
    ],
    correct: 2
  },
  {
    question: "Un medicament de cet groupe est utilisé autrefois comme antihépatite B",
    img: "",
    responses: [
      "Stavadine",
      "Lamivudine",
      "Abacavir",
      "Didanosine",
      "Ténofovir"
    ],
    correct: 1
  },
  {
    question: "Le médicament de groupe NNRTIs.",
    img: "",
    responses: [
      "Névirapine",
      "Indinavir",
      "Ritonavir",
      "Stavudine",
      "Lamivudine"
    ],
    correct: 0
  },
  {
    question: "Les effets indésirables principaux de groupe inhibiteur de protease.",
    img: "",
    responses: [
      "Troubles de motricité",
      "Troubles sensitive",
      "Lipodystrophie",
      "Troubles neurovégétatives",
      "Troubles de vision"
    ],
    correct: 2
  },
  {
    question: "La shéma de traitement le plus légitime de l’infection des Rétro viraux",
    img: "",
    responses: [
      "L’emplou l’inhibiteur du protease seul",
      "L’association NNRTI et NsRTI",
      "L’association Ns RTI + Nt RTI + PI",
      "NNRTI seul",
      "Nt RTI seul."
    ],
    correct: 2
  },
  {
    question: "Le nom abbréviation de ritonavir.",
    img: "",
    responses: [
      "ATC",
      "NVP",
      "EFV",
      "NFV",
      "RTV"
    ],
    correct: 4
  },
  {
    question: "Le nouveau antirétroviraux.",
    img: "",
    responses: [
      "Élitégravir",
      "Stavudine",
      "Lamivudine",
      "Abacavir",
      "Ténofovir"
    ],
    correct: 0
  },
  {
    question: "Le groupe antirétrovireu qui donne une toxication métochondriale.",
    img: "",
    responses: [
      "IP",
      "NRTIs",
      "Nt RTI",
      "Les groups antirétroviraux nouveaux",
      "NNRTI"
    ],
    correct: 1
  },
  {
    question: "Fonction du medicament",
    img: "",
    responses: [
      "Préventive individuelle",
      "Traitement substitutive",
      "Physiologique",
      "Fonction diagnostique",
      "Traitement symptomatique."
    ],
    correct: 2
  },
  {
    question: "Origine des medicaments.",
    img: "",
    responses: [
      "Origine végétale",
      "Origine animale",
      "Origine synthétique",
      "Origine biogénétique",
      "Origine industrielle"
    ],
    correct: 4
  },
  {
    question: "Dénomination des médicaments.",
    img: "",
    responses: [
      "Un nom chimiqne",
      "Dénomination commune internationale",
      "Nom de marque",
      "Dénominations communes nationales",
      "Dénominations communes familiales"
    ],
    correct: 4
  },
  {
    question: "Dénomination commune internationales de cet medicament.",
    img: "",
    responses: [
      "Doliprane",
      "Kinal",
      "Paracétamol",
      "Sara",
      "Efferalgan"
    ],
    correct: 2
  },
  {
    question: "Origine végétale de cet medicament.",
    img: "",
    responses: [
      "Quinine",
      "Strychnine",
      "Ginkor giloba",
      "Digoxine",
      "Ampicilline"
    ],
    correct: 4
  },
  {
    question: "Origine animale de cet médicament",
    img: "",
    responses: [
      "Insuline",
      "Trypsine",
      "Urokinase",
      "Morphine",
      "Chymotrypsine"
    ],
    correct: 3
  },
  {
    question: "Médicaments génériques et medicaments de marque (Brand name)",
    img: "",
    responses: [
      "Crestor",
      "Kinal",
      "Esome",
      "Pilokit",
      "Rabirol."
    ],
    correct: 1
  },
  {
    question: "Le taux de l’alcoolémie qui provoque le coma (g/l)",
    img: "",
    responses: [
      "0.5- 1",
      "1- 2",
      "2- 3",
      "3- 4",
      "> 5"
    ],
    correct: 3
  },
  {
    question: "Conséquence d’une consommation chronique de l’alcool pour le foie et le tube digestif.",
    img: "",
    responses: [
      "Stèatose hépatique",
      "Cirrhose",
      "Pancréatite",
      "Gastrite",
      "Diarrheé chronique"
    ],
    correct: 4
  },
  {
    question: "Conséquence d’une consommation chronique de l’alcool pour le systéme nerveux.",
    img: "",
    responses: [
      "Dépendance physique",
      "Dépendance psychique",
      "Délirium trémens",
      "Neuropathie périphérique",
      "Hémiplégie."
    ],
    correct: 4
  },
  {
    question: "Conséquence d’une consummation chronique de l’alcool pour le systéme endocrine et équilibre hydro életrolytique.",
    img: "",
    responses: [
      "génécomastie",
      "Atrophie testiculaire",
      "Hyperglycémie",
      "Hyperaldostéronisme",
      "Hypokaliémie."
    ],
    correct: 2
  },
  {
    question: "L’Ethanol",
    img: "",
    responses: [
      "Alcool méthalique",
      "Est toxique",
      "Alcool êthylique",
      "Êthyléne glycol",
      "Estmac plein rétarde son absorbtion."
    ],
    correct: 2
  },
  {
    question: "La formule chimique de l’acétadéhyde.",
    img: "",
    responses: [
      "CH3 CH2 OH",
      "CH3 CHO",
      "CH3 COO-",
      "CO2",
      "CH2 OH"
    ],
    correct: 1
  },
  {
    question: "Les medicaments qui donnent l’effet antabuse.",
    img: "",
    responses: [
      "Le Bactrim",
      "Le métronidazole",
      "La céphalosporine",
      "Le paracétamol",
      "Le flagyl"
    ],
    correct: 1
  },
  {
    question: "Les medicaments qui provoqunt la pharmacodépcndance.",
    img: "",
    responses: [
      "Les laxatifs",
      "Salbutamol",
      "Les gluocorticoϊdes",
      "Thiamine",
      "Les tranquilisants"
    ],
    correct: 3
  },
  {
    question: "Les groupes des substances qui provoquent la toxicomanie.",
    img: "",
    responses: [
      "Les hallucinogéne",
      "Les énivrants",
      "Les opiacé et lcurs dérivés",
      "Les excitants",
      "Les myorelaxants"
    ],
    correct: 4
  },
  {
    question: "Les énivrants",
    img: "",
    responses: [
      "Alcool éthylique",
      "L’éther",
      "Le cannabis",
      "Péthidine",
      "Les solvants organiques."
    ],
    correct: 3
  },
  {
    question: "Les psychotropes.",
    img: "",
    responses: [
      "La morphine",
      "Le cannabis",
      "La piradoxine (vit B6)",
      "Le cocaϊne",
      "L’amphétamine"
    ],
    correct: 2
  },
  {
    question: "La morphine est l’extrait de",
    img: "",
    responses: [
      "Cannabis",
      "Pivot",
      "Héroϊne",
      "Cocaine",
      "L’amphêtamine"
    ],
    correct: 1
  },
  {
    question: "Le naloxone est l’antidote de",
    img: "",
    responses: [
      "Cannabis",
      "Cocaine",
      "Diazépam",
      "Morphine",
      "Des solvants organiques."
    ],
    correct: 3
  },
  {
    question: "Les morphiniques de synthèse",
    img: "",
    responses: [
      "Dolosal",
      "Fantanyl",
      "Eubine",
      "Pancodane",
      "Amphétamine"
    ],
    correct: 4
  },
  {
    question: "La dénomination actuelle des médicaments",
    img: "",
    responses: [
      "Substances dangereuses",
      "Substances stupéfiants",
      "Substances substitutives",
      "Sustances psychotropes",
      "Médicaments de liste I et II"
    ],
    correct: 2
  },
  {
    question: "Régles de redaction de l’ordonnance",
    img: "",
    responses: [
      "Dose, horaire de la prise",
      "Individuelle, ne pas antidaté",
      "Lisible, comprise",
      "Emgagement financière",
      "Doit être imprémer pas de signature du médecin"
    ],
    correct: 4
  },
  {
    question: "Il est classé dans la substance stupéfiant",
    img: "",
    responses: [
      "Le laselix",
      "La codeine",
      "Le cannabis",
      "L’éthanol",
      "La digoxine"
    ],
    correct: 2
  },
  {
    question: "Le morphine est classé daus le tableau",
    img: "",
    responses: [
      "Tableau (A)",
      "Tableau (B)",
      "Tableau (C)",
      "Substances daugereux",
      "Substances psychotropes"
    ],
    correct: 1
  },
  {
    question: "La durée maximale de la prescription de la morphine injectable",
    img: "",
    responses: [
      "7 jours",
      "14 jours",
      "28 jours",
      "1 mois",
      "2 mois."
    ],
    correct: 0
  },
  {
    question: "Dispositions particulières des medicaments ā prescription restreinte",
    img: "",
    responses: [
      "Peut acheter danus tous les pharmacie",
      "Peut acheter au pharmacie olympic",
      "Ne nécessite pas d’examiner examen biologique complet",
      "Traitemente ambultoire",
      "Délivrer par la pharmacie hospitaliére"
    ],
    correct: 4
  },
  {
    question: "Les medicaments orphelins",
    img: "",
    responses: [
      "Pour les enfants qui n’ont pas des parents",
      "Côute trés chers",
      "Réserver dans l’hopital publique",
      "Médicaments ont une importance particulière en pédiatrie prescritent pas les professeurs specialists",
      "Peut acheter dans tous les pharmacies."
    ],
    correct: 3
  },
  {
    question: "Le traitement contre les dermophytes",
    img: "",
    responses: [
      "Fonngizone",
      "Miconazole",
      "Griséofulvine",
      "Fluconazole",
      "Itraconazole."
    ],
    correct: 2
  },
  {
    question: "Antimycosiques employés pour traitement des dandruf (Pélicules) de le shampoo",
    img: "",
    responses: [
      "Miconazole",
      "Daktarin",
      "Ketoconazole",
      "Fluconazole",
      "Itraconazole"
    ],
    correct: 2
  },
  {
    question: "Traitement du pityriasis versicolor",
    img: "",
    responses: [
      "Gel daktarin",
      "Mycostatine",
      "Candaole gel",
      "Griséofulvine",
      "Kétoderme."
    ],
    correct: 2
  },
  {
    question: "Les antifongiques imidazolés",
    img: "",
    responses: [
      "Miconazole",
      "Kétoconazole",
      "Métronidazole",
      "Itraconazole",
      "Fluconazole."
    ],
    correct: 2
  },
  {
    question: "Le traitement de méningites ā crytococcose après le fungizone pour relayer le traitement",
    img: "",
    responses: [
      "Griséofulvine",
      "Fluconazole",
      "Terbinafine",
      "Flucytosine",
      "Kétoconazole"
    ],
    correct: 1
  },
  {
    question: "Antifongique utilisé empirique dans le traitement en rhumatologie",
    img: "",
    responses: [
      "Kétoconazole",
      "Fluconazole",
      "Griséofulvine",
      "Terbinafine",
      "Flucytosine"
    ],
    correct: 2
  },
  {
    question: "Le DCI denomination commun international de fungizone",
    img: "",
    responses: [
      "Imidazole",
      "Terbinafine",
      "Amphotéricine (B)",
      "Griséofulvine",
      "Flucytosine."
    ],
    correct: 2
  },
  {
    question: "L’acide utilisé pour préservèr l’alimcntatiou de conservé",
    img: "",
    responses: [
      "L’acide acétique",
      "L’acide benzoique",
      "L’acide borique",
      "L’acide lactique",
      "L’acide chloridrique"
    ],
    correct: 1
  },
  {
    question: "Substance colorée pour désinfecter les légumes",
    img: "",
    responses: [
      "Bétadine",
      "Chlorcxidine",
      "Permanganate de potassium",
      "Nitrate d’argent",
      "L’acide borique"
    ],
    correct: 2
  },
  {
    question: "Substance iodée pour désinfecter la peau et les mucqueuses.",
    img: "",
    responses: [
      "Pormanganate de potassium",
      "Acide acétique",
      "Formol",
      "Chloramine",
      "Bétadine"
    ],
    correct: 4
  },
  {
    question: "Substance pour présesver les pièces anatomiques pour l’examen anatomopathologique",
    img: "",
    responses: [
      "Acide chloridrique",
      "Bétadine",
      "Formol",
      "Chlorexidine",
      "L’acide borique"
    ],
    correct: 2
  },
  {
    question: "Dérivée des métaux utilisés comme antiseptique",
    img: "",
    responses: [
      "Chloramine",
      "Ethanol",
      "Le phénol",
      "Nitrate d’argent",
      "Acide acétique"
    ],
    correct: 3
  },
  {
    question: "Bétadine",
    img: "",
    responses: [
      "Alcool + chlore",
      "Alcool + ac borique",
      "Alcool + composés idées",
      "Alcool + nitrate d’argent",
      "Alcool + phénol"
    ],
    correct: 2
  },
  {
    question: "Antiseptique provoquant des bulles au contact des plaies",
    img: "",
    responses: [
      "Permanganate de potassium",
      "Teinture d’iode",
      "Nitrate d’argent",
      "Eau oxygéné",
      "Acide Benzoique"
    ],
    correct: 3
  },
  {
    question: "La voie la plus pratique et commodité",
    img: "",
    responses: [
      "Intramusculaire",
      "Orale",
      "Intraveineuse",
      "Cutanée",
      "Inhalation"
    ],
    correct: 1
  },
  {
    question: "Le choix d’une voie d’administration depend",
    img: "",
    responses: [
      "Situation urgence",
      "Volume importance ā administer",
      "Action locale",
      "Action générale",
      "Qualité du médicament"
    ],
    correct: 4
  },
  {
    question: "La voie le plus commode pour le traitement d’une petite plaie cutanée",
    img: "",
    responses: [
      "Intramusculaire",
      "Intraveineuse",
      "Cutanée locale",
      "Orale",
      "Inhalation"
    ],
    correct: 2
  },
  {
    question: "La voie la plus utilisée en reanimation",
    img: "",
    responses: [
      "Intracardiaque",
      "Cutanée",
      "Inhalation",
      "Orale",
      "Intraveinse"
    ],
    correct: 4
  },
  {
    question: "La voie que l’on peut domner une grande quantiée de liquide dans le choc hypovolumique",
    img: "",
    responses: [
      "Intramusculaire",
      "Intraveineuse périphérique",
      "Voie veineuse sous clavière",
      "Intraveineuse cérébrale",
      "Orale"
    ],
    correct: 2
  },
  {
    question: "Les vioes combinées utilisées dans la chirurgie de lougue dureè",
    img: "",
    responses: [
      "Orale et intraveineuse",
      "Inhalation et intramusalaire",
      "Orale et intramusculaire",
      "Intramusculaire et intraveineuse",
      "Inhalation et intraveineuse"
    ],
    correct: 4
  },
  {
    question: "La voie utiliée pour traiter les maladies parasitaires intestinales",
    img: "",
    responses: [
      "Voie cutanée",
      "Inhalation",
      "Intraveineuse",
      "Orale",
      "Intramusculaire"
    ],
    correct: 3
  },
  {
    question: "Le dose médicamenteux ideal d’un sejet de 84as",
    img: "",
    responses: [
      "65% de la dose adulte",
      "10% de la dose adulte",
      "80% de la dose adulte",
      "50% de la dose adulte",
      "70% de la dose adulte"
    ],
    correct: 3
  },
  {
    question: "La dose de la dopamine pour avoir action diurétique.",
    img: "",
    responses: [
      "7µg/ kg / h",
      "10µg/ kg / h",
      "5µg/ kg / h",
      "20µg/ kg / h",
      "30µg/ kg / h"
    ],
    correct: 2
  },
  {
    question: "La dose de ceftriaxoue utilisé par jour chez un adulte de 40kg atteint de pneumonic.",
    img: "",
    responses: [
      "1g/ J",
      "2g/ J",
      "6g/ J",
      "5g/ J",
      "3g/ J"
    ],
    correct: 1
  },
  {
    question: "La dose rifampicine daus traitement de la tuberculose pulmonaire.",
    img: "",
    responses: [
      "5mg/kg",
      "10mg/kg",
      "15mg/kg",
      "20mg/kg",
      "25mg/kg"
    ],
    correct: 1
  },
  {
    question: "Quél examen pour évaluer la dose médicamenteuse exact pour les personnes âgées",
    img: "",
    responses: [
      "Trausaminase",
      "Hêmogramme",
      "Clearauce de la créatinine",
      "Urèe sauguin",
      "Ionogramme"
    ],
    correct: 2
  },
  {
    question: "La dose maximale de diamicron MR qu’ou peut donner au patient diabètique type II de l’adulte.",
    img: "",
    responses: [
      "30mg",
      "60mg",
      "90mg",
      "50mg",
      "120mg"
    ],
    correct: 4
  },
  {
    question: "La dose journaliére de la streptomycine (aminoside) chez les adultes",
    img: "",
    responses: [
      "500mg",
      "1g",
      "2g",
      "3g",
      "4g"
    ],
    correct: 1
  },
  {
    question: "Les récepteurs adrénergiques se trouvent au niveau postsynaptique:",
    img: "",
    responses: [
      "des ganglions sympathiques",
      "des ganglions parasympathiques",
      "des terminaisons sympathiques",
      "des terminaisons parasypmpathiques",
      "des muscles squelettiques"
    ],
    correct: 2
  },
  {
    question: "La dopamine est le produit du catabolisme:",
    img: "",
    responses: [
      "des gonadotrophines",
      "de la vasopressine",
      "des glucocorticoides",
      "de la tyrosine",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Le disulfurane est un inhibiteur du catabolisme:",
    img: "",
    responses: [
      "de la tyrosine",
      "du L-dopa",
      "de la dopamine",
      "de la noradrénaline",
      "Tous"
    ],
    correct: 2
  },
  {
    question: "Les organes suivants sont riches en noradrénaline, sauf:",
    img: "",
    responses: [
      "la médullosurénale",
      "le coeur",
      "les vaisseaux",
      "le cerveau",
      "tous"
    ],
    correct: 0
  },
  {
    question: "Suivant les étapes successifs dans la biogénèse des cathécholamines, l’activation du catabolisme se fait par hydroxylation, sauf :",
    img: "",
    responses: [
      "la phénylalanine en tyrosine",
      "la tyrosine en L-dopa",
      "la L-dopa en dopamine",
      "la dopamine en noradrénaline",
      "tous"
    ],
    correct: 2
  },
  {
    question: "Suivant les étapes successifs dans la biogénèse des cathécholamines, l’inhibition du catabolisme se fait par méthylation, sauf:",
    img: "",
    responses: [
      "la tyrosine en L-dopa",
      "la L-dopa en dopamine",
      "la dopamine en noradrénaline",
      "la noradrénaline en adrénaline",
      "tous"
    ],
    correct: 3
  },
  {
    question: "Lequel des médicaments suivants est utilisé dans l’hypotension orthostatique:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "méthylergotamine",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel de ces médicaments suivants utilisé dans la migraine:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "méthylergotamine",
      "Tous"
    ],
    correct: 1
  },
  {
    question: "Les médicaments suivants sont utilisés pour le traitement préventif des crises d'asthme, sauf:",
    img: "",
    responses: [
      "Salbutamol: Ventoline* inj amp 5 mg",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pour inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Terbutaline: Bricanyl* comp LP 5mg"
    ],
    correct: 0
  },
  {
    question: "Les médicaments suivants sont utilisés pour le traitement préventif des crises d'asthme, sauf:",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* inj amp 5mg",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pou inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Terbutaline: Bricanyl* comp LP 5mg"
    ],
    correct: 0
  },
  {
    question: "Les médicaments suivants sont utilisés pour le traitement préventif de la bronchopneumopathie chronique obstructive, sauf:",
    img: "",
    responses: [
      "Salbutamol: Ventoline* inj amp 5 mg",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pou inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Les médicaments suivants sont utilisés pour le traitement préventif de la bronchopneumopathie chronique obstructive, sauf:",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* inj amp 5mg",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pou inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des médicaments suivants est utilisé pour le traitement de menace d’accouchement prématuré:",
    img: "",
    responses: [
      "Salbutamol: Ventoline* inj amp 5 mg",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pou inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des médicament suivants est utilisé pour le traitement de menace d’accouchement prématuré:",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* inj amp 5mg",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pou inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des médicaments suivants est utilisé pour le traitement des crises d'asthme :",
    img: "",
    responses: [
      "Salbutamol: Ventoline* pour inhalation",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pou inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des médicaments est utilisé pour le traitement des crises d'asthme :",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* pour inhalation",
      "Salmétérol: Sérévent* aérosol, poudre pour inhalation",
      "Formotérol: Foradil* aérosol, poudre pou inhalation",
      "Bambutérol: Oxéol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Parmi les médicaments suivants, lequel agit au niveau des récepteurs cardiaques:",
    img: "",
    responses: [
      "salbutamol",
      "terbutaline",
      "dobutamine",
      "formotérol",
      "aucun"
    ],
    correct: 2
  },
  {
    question: "Lequel des médicaments suivants est utilisé dans l’hémorragie de la délivrance:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "méthylergotamine",
      "Tous"
    ],
    correct: 3
  },
  {
    question: "Lequel des médicaments suivants est utilisé dans la congestion nasale:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "méthylergotamine",
      "Tous"
    ],
    correct: 2
  },
  {
    question: "Lequel des antihypertenseurs suivants agit également sur la rénine:",
    img: "",
    responses: [
      "clonidine",
      "alphamethyldopa",
      "α1-bloquant",
      "β-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Lequel des antihypertenseurs suivants est indiqué dans le traitement préventif de l’angor:",
    img: "",
    responses: [
      "clonidine",
      "alphaméthyldopa",
      "α1-bloquant",
      "β-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Lequel des antihypertenseurs suivants est utilisé en cas de tachycardie (p.e dans la maladie de Basedow):",
    img: "",
    responses: [
      "clonidine",
      "alphaméthyldopa",
      "α1-bloquant",
      "β-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Lequel des antihypertenseurs suivants agit comme un faux médiateur de la noradrénaline:",
    img: "",
    responses: [
      "clonidine",
      "alphaméthyldopa",
      "α1-bloquant",
      "β-bloquant",
      "aucun"
    ],
    correct: 1
  },
  {
    question: "Lequel des antihypertenseurs suivants agit au niveau des récepteurs α2-présynaptiques centraux:",
    img: "",
    responses: [
      "clonidine",
      "alphaméthyldopa",
      "α1-bloquant",
      "β-bloquant",
      "aucun"
    ],
    correct: 1
  },
  {
    question: "Lequel des antihypertenseurs suivants est utilisé dans le traitement préventif dans les hémorragies par rupture des varices oesophagiennes:",
    img: "",
    responses: [
      "clonidine",
      "alphaméthyldopa",
      "α1-bloquant",
      "β-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Parmi les médicaments suivants, lequel est utilisé dans le traitement des artérites des membres inférieurs:",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 1
  },
  {
    question: "Parmi les médicaments suivants, lequel est utilisé dans le traitement de l’hypotension orthostatique:",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 0
  },
  {
    question: "Parmi les médicaments suivants, lequel est utilisé dans le traitement de fond de la migraine :",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 3
  },
  {
    question: "Parmi les médicaments lequel est utilisé dans le traitement des troubles cérébraux de la sénescence",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 2
  },
  {
    question: "Les propositions suivantes concernent le β-bloquants liposolubles, sauf:",
    img: "",
    responses: [
      "ils ont un effet de premier passage hépatique",
      "ils ont une interaction médicamenteuse au niveau du foie",
      "ils sont contre-indiqués en cas d’insuffisance hépatique",
      "ils peuvent être utilisés en cas d'état dépressif",
      "ils ont une fixation protéique élevée"
    ],
    correct: 3
  },
  {
    question: "Les propositions suivantes concernent le bétabloquants hydrosolubles, sauf:",
    img: "",
    responses: [
      "ils ont d’effet de premier passage hépatique",
      "ils sont excrété au niveau du rein",
      "ils sont contre-indiqués en cas d’insuffisance rénale",
      "ils peuvent être utilisés en cas d'état dépressif",
      "ils ont une fixation protéique faible"
    ],
    correct: 0
  },
  {
    question: "Parmi ces β-bloquants non cardiosélectifS, lequel possède une activité sympathomimétique intrinsèque :",
    img: "",
    responses: [
      "propanolol",
      "Sotalol",
      "Timolol",
      "Pindolol",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Ces β-bloquants cardiosélectifS ne possèdent pas une activité sympathomimétique intrinsèque, sauf :",
    img: "",
    responses: [
      "propanolol",
      "Sotalol",
      "Timolol",
      "Pindolol",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Parmi ces β-bloquants cardiosélectifS, lequel possède une activité sympathomimétique intrinsèque :",
    img: "",
    responses: [
      "Bisoprolol",
      "Métoprolol",
      "Aténolol",
      "Acébutolol",
      "Aucun"
    ],
    correct: 1
  },
  {
    question: "Ces β-bloquants cardiosélectifS ne possèdent pas une activité sympathomimétique intrinsèque, sauf :",
    img: "",
    responses: [
      "Bisoprolol",
      "Métoprolol",
      "Aténolol",
      "Acébutolol",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Lequel des antidépresseurs suivants porte le nom de spécialité LAROXYL*:",
    img: "",
    responses: [
      "doxépine",
      "imipramine",
      "amitriptyline",
      "mapropiline",
      "Aucun"
    ],
    correct: 2
  },
  {
    question: "Lequel des antidépresseurs suivants porte le nom de spécialité QUITAXON*:",
    img: "",
    responses: [
      "doxépine",
      "imipramine",
      "amitriptyline",
      "mapropiline",
      "Aucun"
    ],
    correct: 0
  },
  {
    question: "Lequel des antidépresseurs suivants porte de spécialité TOFRANIL*:",
    img: "",
    responses: [
      "doxépine",
      "imipramine",
      "amitriptyline",
      "mapropiline",
      "Aucun"
    ],
    correct: 1
  },
  {
    question: "Lequel des antidépresseurs suivants porte de spécialité STABLON*:",
    img: "",
    responses: [
      "tianeptine",
      "miansérine",
      "mirtazapine",
      "duloxétine",
      "Aucun"
    ],
    correct: 0
  },
  {
    question: "Lequel des antidépresseurs suivants porte de spécialité NORSET*:",
    img: "",
    responses: [
      "tianeptine",
      "miansérine",
      "mirtazapine",
      "duloxétine",
      "Aucun"
    ],
    correct: 2
  },
  {
    question: "Lequel des médicaments suivants utilisés en psychiatrie est un psychostimulant:",
    img: "",
    responses: [
      "halopéridol",
      "modafinil",
      "mirtazapine",
      "amitriptyline",
      "Aucun"
    ],
    correct: 1
  },
  {
    question: "L’action de médiateurs chimiques du système nerveux végétatif est :",
    img: "",
    responses: [
      "Indépendant de la volonté",
      "Dépendant de la volonté",
      "Indépendant de l’automatico-volonté",
      "Dépendant de l’automatico-volonté",
      "Indépendant de système nerveux central"
    ],
    correct: 0
  },
  {
    question: "L’action de médiateurs chimiques du système nerveux végétatif règle :",
    img: "",
    responses: [
      "Le réflexe",
      "Les sécrétions des glandes endocrines et exocrines",
      "La respiration",
      "Le système nerveux central",
      "Le système nerveux somatique"
    ],
    correct: 1
  },
  {
    question: "Le trajet de l’action de médiateurs chimiques du système sympathique est traversé par :",
    img: "",
    responses: [
      "Ses centres bulbo-sacrés",
      "Ses centres thoraco-lombaires",
      "Ses fibres (neurones) préganglionnaires longs",
      "Ses synapses ganglionnaires se trouvant dans la paroi même des viscères",
      "Ses fibres postganglionnaires très courts"
    ],
    correct: 1
  },
  {
    question: "Au contraire, le trajet de l’action de médiateurs chimiques du système sympathique est traversé par :",
    img: "",
    responses: [
      "Ses centres bulbo-sacrés",
      "Ses centres thoraco-lombaires",
      "Ses fibres (neurones) préganglionnaires courts",
      "Ses synapses ganglionnaires paravertébraux",
      "Ses fibres postganglionnaires longs"
    ],
    correct: 0
  },
  {
    question: "Le médiateur chimique des synapses ganglionnaires est l’acétylcholine, mais ses récepteurs cholinergiques de :",
    img: "",
    responses: [
      "Type nicotinique",
      "Type adrénergique",
      "Type dopaminergique",
      "Type muscarinique",
      "Types nicotinique et muscarinique"
    ],
    correct: 0
  },
  {
    question: "L’acétylcholine est libérée :",
    img: "",
    responses: [
      "Dans les terminaisons du parasympathique avec ses récepteurs étant de type nicotinique",
      "Dans les terminaisons du parasympathique avec ses récepteurs étant de type muscarinique",
      "Dans les synapses ganglionnaires du système nerveux autonome avec ses récepteurs étant de type muscarinique",
      "Dans les plaques motrices avec ses récepteurs étant de type muscarinique",
      "Dans le système nerveux central avec les deux types de récepteurs coexistent"
    ],
    correct: 1
  },
  {
    question: "Dans les terminaisons présynaptique :",
    img: "",
    responses: [
      "L’acétylcholine contenue dans des vésicules",
      "Les cholinestérases contenuent dans des vésicules",
      "La choline contenue dans des vésicules",
      "La co-enzyme (A) contenue dans des vésicules",
      "L’acétyl co-enzyme (A) contenue dans des vésicules"
    ],
    correct: 0
  },
  {
    question: "Les effets muscariniques de l’acétylcholine à faible dose stimulent le parasympathique au niveau des organes effecteurs tels que :",
    img: "",
    responses: [
      "Les effets cardiaques et vasculaires sont l’augmentation de la tension artérielle immédiate et fugace",
      "Les effets sur les fibres musculaires lisses des viscères sont la diminution du péristaltisme intestinal",
      "Les effets sur les sécrétions sont la diminution des sécrétions digestives",
      "Les effets sur l’œil sont la mydriase",
      "Les effets centraux sont complexes et mal connus"
    ],
    correct: 4
  },
  {
    question: "Les effets nicotiniques de l’acétylcholine à forte dose stimulent le ganglion synaptique tels que :",
    img: "",
    responses: [
      "Une libération d’acétylcholine est par les terminaisons du sympathique",
      "Une libération de la noradrénaline est par les terminaisons du parasympathique",
      "Un relâchement musculaire est au niveau de la plaque motrice",
      "Les rôles des récepteurs muscariniques et nicotiniques sont faciles à discerner au niveau du système nerveux central",
      "Une libération d’acétylcholine est par les terminaisons du parasympathique"
    ],
    correct: 4
  },
  {
    question: "L’acétylcholine est le médiateur chimique :",
    img: "",
    responses: [
      "Des synapses cholinergiques dans le système nerveux central",
      "Des terminaisons du sympathique",
      "Des terminaisons du système nerveaux autonome",
      "Des terminaisons du système nerveaux somatique",
      "Des ganglons et des terminaisons du sympathique"
    ],
    correct: 0
  },
  {
    question: "L’indication thérapeutique de l’acétylcholine est :",
    img: "",
    responses: [
      "Les applications cliniques généralisées",
      "Utilisée en solution extra-oculaire",
      "Pour une mydriase au cours de la chirurgie oculaire",
      "Les applications cliniques limitées pour la fugacité d’action",
      "Utilisée en solution intra-oculaire (peropératoire) pour l’action prolongée"
    ],
    correct: 3
  },
  {
    question: "Les cholinomimétiques peuvent s’utiliser dans :",
    img: "",
    responses: [
      "Le traitement du glaucome",
      "L’asthme bronchique",
      "L’intoxication par les insecticides organophosphorés",
      "Le mal des transports",
      "La prémédication anesthésique"
    ],
    correct: 0
  },
  {
    question: "L’acétylcholine :",
    img: "",
    responses: [
      "Produit un myosis passif",
      "Agit sur les récepteurs muscariniques",
      "Agit sur les récepteurs alpha 2 adrénergiques",
      "Est indiquée dans les asthmes",
      "Est contre-indiquée en cas d’hypertrophie prostatique"
    ],
    correct: 1
  },
  {
    question: "Parmi les groupes pharmacologiques suivants, cochez celui qui est contre-indiqué chez l’asthmatique :",
    img: "",
    responses: [
      "Les stimulants alpha adrénergiques",
      "Les anticholinestérasiques",
      "Les sympathomimétiques",
      "Les parasympathomimétiques",
      "Les bloquants béta adrénergiques"
    ],
    correct: 1
  },
  {
    question: "La nicotine :",
    img: "",
    responses: [
      "Entraîne la polypnée",
      "N’a pas d’une action anxiolytique",
      "Provoque des tremblements à faible dose",
      "Est responsable d’une chute de la pression artérielle",
      "Est le composant responsable de la cancérisation des voies respiratoires"
    ],
    correct: 0
  },
  {
    question: "Les anticholinestérasiques réversibles :",
    img: "",
    responses: [
      "Sont les effets essentiellement muscariniques",
      "Ont l’action centrale",
      "Ne sont pas indiquées dans le traitement symptomatique de la maladie d’Alzeimer",
      "Ne sont pas de troubles digestifs",
      "Conduisent à une chute de la concentration d’acétylcholine"
    ],
    correct: 0
  },
  {
    question: "Le Sarin est :",
    img: "",
    responses: [
      "L’anticholinestérasique réversible",
      "L’anticholinestérasique irréversible",
      "L’atropinique",
      "La ganglioplégique",
      "Le curarisant"
    ],
    correct: 1
  },
  {
    question: "Les signes muscariniques d’anticholinestérasique irréversible sont :",
    img: "",
    responses: [
      "Mydriase",
      "Myosis",
      "Tachycardie",
      "Sécheresse de la bouche",
      "Hyposudation"
    ],
    correct: 1
  },
  {
    question: "Les signes nicotiniques d’anticholinestérasique irréversible sont :",
    img: "",
    responses: [
      "Bradycardie",
      "Chute de la pression artérielle",
      "Tachycardie",
      "Tremblement",
      "Myosis"
    ],
    correct: 2
  },
  {
    question: "Quel est l’antispasmodique qui possède des propriés atropiniques ?",
    img: "",
    responses: [
      "Papavérine",
      "Mébévérine (Duspatalin®)",
      "La Khelline",
      "La Trimébutine (Débridat®)",
      "Le Tiémonium (Viscéralgine®)"
    ],
    correct: 4
  },
  {
    question: "L’activité anticholinergique, source d’effet indésirable, peut se rencontrer dans les classes médicamenteuses suivantes sauf une, indiquer laquelle :",
    img: "",
    responses: [
      "Morphines",
      "Antidépresseurs tricycliques",
      "Neuroleptiques",
      "Antihistaminiques",
      "Antispasmodiques du tube digestif"
    ],
    correct: 0
  },
  {
    question: "Les propositions suivantes concernent les actions que les médicaments parasympathiques (ou atropiniques) peuvent produire. Laquelle de ces propositions est inexacte ?",
    img: "",
    responses: [
      "Tachycardie",
      "Relaxation de l’intestin",
      "Relaxation des bronches",
      "Relaxation du sphincter vésical",
      "Mydriase"
    ],
    correct: 4
  },
  {
    question: "L’atropine est un médicament :",
    img: "",
    responses: [
      "Anticholinestérasique",
      "Acétylchonomimétique",
      "Sympatholytique",
      "Anticholinergique",
      "Sympathomimétique"
    ],
    correct: 3
  },
  {
    question: "L’atropine exerce tous les effets suivants sauf un, lequel ?",
    img: "",
    responses: [
      "Tachycardie",
      "Bronchodilatation",
      "Réduction du péristaltisme intestinal",
      "Mydriase",
      "Augmente des sécrétions digestives"
    ],
    correct: 4
  },
  {
    question: "Parmi les effets secondaires suivants, indiquer celui que l’on peut voir avec un médicament atropinique :",
    img: "",
    responses: [
      "Myosis",
      "Diarrhée",
      "Rétention urinaire",
      "Hypersialorrhée",
      "Hypersécrétion bronchique"
    ],
    correct: 2
  },
  {
    question: "Quel est, parmi les effets suivants, celui qui est susceptible d’être produit par une substance cholinolytique muscarinique ?",
    img: "",
    responses: [
      "Bradycardie",
      "Allongement du temps de conduction auriculo-ventriculaire",
      "Augmentation des sécrétions sudorales",
      "Augmentation du diamètre pupillaire",
      "Bronchoconstriction"
    ],
    correct: 1
  },
  {
    question: "Quelle est la contre-indication d’emploi des cholinolytiques muscariniques ?",
    img: "",
    responses: [
      "Hypertension artérielle",
      "Adénome prostatique",
      "Allaitement",
      "Glaucome à angle fermé",
      "Grossesse"
    ],
    correct: 1
  },
  {
    question: "Chez un malade parkisonien, l’Artane® :",
    img: "",
    responses: [
      "Facilite la libération de la dopamine",
      "Agit sur les récepteurs de la dopamine",
      "Agit sur les systèmes cholinergiques",
      "Ne peut pas aggraver des troubles cognitifs",
      "Provoque un myosis"
    ],
    correct: 2
  },
  {
    question: "L’atropinique :",
    img: "",
    responses: [
      "Est un inhibiteur compétitif des récepteurs cholinergiques muscariniques",
      "Se traduit par une augmentation du tonus du parasympathique",
      "Provoque une élévation de la tension artérielle",
      "Provoque le myosis",
      "Provoque la bradycardie"
    ],
    correct: 0
  },
  {
    question: "Effet bactéricide ?",
    img: "",
    responses: [
      "Diminution de la pouvoir pathogène bactérienne",
      "Ralentissement de la multiplication bactérienne",
      "La mort des bactéries",
      "La mort des microbes",
      "Prolongement du temps de la division cellulaire."
    ],
    correct: 2
  },
  {
    question: "Effet bactériostatique",
    img: "",
    responses: [
      "Tuer des bactéries",
      "Ralentissement de la multiplication bactérienne",
      "Diminution de la pouvoir pathogène bactérienne",
      "Inhibition de la division cellulaire microbienne",
      "Augmentation de la pouvoir pathogène bactérienne."
    ],
    correct: 1
  },
  {
    question: "La bactérie résistance peut être à un antibiotique et s’étendre à un autre antibiotique dans une même famille d’antibiotiques, on appel :",
    img: "",
    responses: [
      "La résistance naturelle",
      "La résistance chromosomique",
      "La résistance acquise",
      "La résistance extra-chromosomique",
      "La résistance croisée"
    ],
    correct: 4
  },
  {
    question: "La résistance d’une bactérie: insensibilité d’emblée c’est la résistance d’espèces, on appel :",
    img: "",
    responses: [
      "La résistance acquise par transfert",
      "La résistance acquise par mutation",
      "La résistance extra-chromosomique",
      "La résistance croisée",
      "La résistance naturelle"
    ],
    correct: 4
  },
  {
    question: "La résistance d’une espèce (bactérie) d’abord sensible puis devient insensible (après augmente brutale de la dose), c’est la résistance ?",
    img: "",
    responses: [
      "La résistance acquise par mutation",
      "La résistance extra-chromosomique",
      "La résistance acquise",
      "La résistance naturelle",
      "La résistance croisée"
    ],
    correct: 2
  },
  {
    question: "Mécanisme d’action: des sulfamides antibactériens agissent par quel mécanisme ?",
    img: "",
    responses: [
      "Interférence avec le métabolisme de l’acide para-aminobenzoïque",
      "Action sur la paroi bactérienne",
      "Action sur la structure de la membrane cytoplasmique",
      "Action sur la synthèse protéique",
      "Action sur les ribosomes bactériens"
    ],
    correct: 0
  },
  {
    question: "Le sulfamide antibactérien a était extrait de",
    img: "",
    responses: [
      "un colorant azoïque (le PRONTOSIL)",
      "l’acide para-aminobenzoïque",
      "genre streptomyces",
      "moisissures",
      "des cultures de .B. brevis"
    ],
    correct: 0
  },
  {
    question: "On utilise les Sulfamides non résorbables pour traiter ?",
    img: "",
    responses: [
      "les infections des voies urinaires",
      "les infections des voies respiratoires",
      "les infections des sphères ORL",
      "la fièvre typhoïde",
      "désinfectant des voies digestives"
    ],
    correct: 4
  },
  {
    question: "La voie d’élimination principale des sulfamides ?",
    img: "",
    responses: [
      "voie sanguine",
      "voie fécale",
      "voie rénale",
      "voie biliaire",
      "voie salivaire"
    ],
    correct: 2
  },
  {
    question: "Les Sulfamides associés ?",
    img: "",
    responses: [
      "Sulfamide + Acide clavulanique",
      "Sulfamide + Trimethoprime",
      "Sulfamide + Sulbactam",
      "Sulfamide + Acide folique",
      "Sulfamide + Tazobactam"
    ],
    correct: 1
  },
  {
    question: "Mécanisme d’action: Les bêta-lactamines agissent par quel mécanisme ?",
    img: "",
    responses: [
      "Action sur la synthèse protéique",
      "Interférence avec le métabolisme de l’acide para-aminobenzoïque",
      "Action sur la paroi bactérienne",
      "Action sur la structure de la membrane cytoplasmique",
      "Action sur les ribosomes bactériens"
    ],
    correct: 2
  },
  {
    question: "Parmi les Pénicillines suivantes, quelle est la Pénicillines M ?",
    img: "",
    responses: [
      "la benzyl-pénicilline",
      "l’amoxicilline",
      "la phénoxyméthyl-pénicilline",
      "la benzathine-pénicilline",
      "la cloxacilline"
    ],
    correct: 4
  },
  {
    question: "Parmi les Pénicillines suivantes, quelle est la Pénicillines antipyocianique ?",
    img: "",
    responses: [
      "Ticarcilline",
      "Ampicilline",
      "Oxacilline",
      "Benzyl-pénicilline",
      "Extancilline"
    ],
    correct: 0
  },
  {
    question: "L’antibiotique aminosidique ne doit pas être administré avec un curare car il y a risque accru de ?",
    img: "",
    responses: [
      "Somnolence",
      "agitation",
      "dépression respiratoire",
      "hallucination",
      "toxicité cochléo–vestibulaire."
    ],
    correct: 2
  },
  {
    question: "Une diminution de l’efficacité des tétracyclines peut être observée lors de l’association avec ?",
    img: "",
    responses: [
      "les diurétiques thiazidiques",
      "un régime à base de lait et de laitages",
      "les sulfamides",
      "les méthicilline",
      "les médicaments antifongiques."
    ],
    correct: 1
  },
  {
    question: "Chez la femme enceinte il est contre - indiqué de prescrire ?",
    img: "",
    responses: [
      "les aminosides",
      "la pénicilline .G",
      "la pénicilline .M",
      "la spiramycines",
      "l’érythromycine."
    ],
    correct: 0
  },
  {
    question: "Un patient a une insuffisance rénale. Vous voulez lui prescrire de la doxycycline: par apport aux doses et aux intervalles habituels d’administration:",
    img: "",
    responses: [
      "Vous ne modifiez pas la dose mais vous diminuez l’intervalle d’administration",
      "Vous diminuez la dose sans modifier l’intervalle d’administration",
      "Vous ne modifiez pas la dose mais vous doublez l’intervalle d’administration",
      "Vous diminuez la dose de moitié en doublant l’intervalle d’administration",
      "Vous ne modifiez ni la dose, ni l’intervalle d’administration"
    ],
    correct: 4
  },
  {
    question: "Les aminosides sont caractérisés par:",
    img: "",
    responses: [
      "une bonne activité sur les pneumocoques",
      "une bonne absorption digestive",
      "une élimination rénale prépondérante",
      "une bonne diffusion méningée",
      "une bonne activité sur les anaérobies."
    ],
    correct: 2
  },
  {
    question: "Il est possible d’éviter les accidents de néphrotoxicité de la gentamicine en évitant ?",
    img: "",
    responses: [
      "la surveillance des taux sériques",
      "l’adaptation des doses en fonction du degré d’insuffisance rénale",
      "la correction d’une éventuelle déshydratation",
      "Maintien d’une diurèse importante au moyen de Lasilix",
      "l’injection PIV continue à forte dose de la gentamicine"
    ],
    correct: 4
  },
  {
    question: "Chez un individu dont les fonctions rénales sont normales, les atibiotiques suivants peuvent exercer une action néphrotoxique directe même lorsque leur posologie est normale:",
    img: "",
    responses: [
      "les bêtalactamines",
      "les licosanides",
      "les macrolides",
      "les aminoglycosides",
      "les cyclines."
    ],
    correct: 3
  },
  {
    question: "Les aminosides sont ototoxiques. Quelle est la structure atteinte, parmi les suivantes ?",
    img: "",
    responses: [
      "l’oreille moyenne",
      "les nerfs auditifs",
      "les voies auditives",
      "les zones d’intégration corticale",
      "la trompe d’Eustache."
    ],
    correct: 1
  },
  {
    question: "Quel est l’antibiotique actif sur la pneumonie à Pneumocystis Jiroveci ?",
    img: "",
    responses: [
      "Gentamycine",
      "Colistine",
      "Pénicilline",
      "Cotrimoxazole",
      "Acide nalidixique."
    ],
    correct: 3
  },
  {
    question: "Parmi les antibactériens suivants, lequel a une bonne diffusion méningée, permettant leur emploi par voie générale pour les traitements des méningites purulentes aigus de l’enfant ?",
    img: "",
    responses: [
      "Céfotaxime",
      "Gentamycine",
      "Tétracyclines",
      "Kanamycine"
    ],
    correct: 0
  },
  {
    question: "Indiquer l’antibiotique présentant un accident de phototoxicité grave ?",
    img: "",
    responses: [
      "Ofloxacine",
      "Doxycline",
      "Erythromycine",
      "Ampicilline",
      "Cloxacilline."
    ],
    correct: 0
  },
  {
    question: "Un des antibiotiques suivants, laquelle est particulièrement indiqué dans le BK.?",
    img: "",
    responses: [
      "Cotrime",
      "Ofloxacine",
      "Céphalosporine",
      "Minocycline",
      "Isoniazide"
    ],
    correct: 4
  },
  {
    question: "Parmi les antibiotiques cités ci-dessous, qui n’est jamais actif sur le BK, lequel?",
    img: "",
    responses: [
      "I N H",
      "Pyrazinamide",
      "Dapsone",
      "Rifampicine",
      "Etambutol."
    ],
    correct: 2
  },
  {
    question: "Les accidents cutanés ci-dessous sont causés par les sulfamides, quel est celui qui est le plus sévère?",
    img: "",
    responses: [
      "Syndrome de Stevens–Jonhson",
      "Syndrome de Lyell",
      "Eruptions cutanés scarlatiniforme",
      "Toxidermie",
      "Erythrodermie."
    ],
    correct: 1
  },
  {
    question: "Les antibiotiques suivants quel est peut indiquer en car de méningite bactérienne ?",
    img: "",
    responses: [
      "Sisoline",
      "Rovamycine",
      "Oxytétracycline",
      "Cotrimoxazole",
      "Gentamycine."
    ],
    correct: 3
  },
  {
    question: "Le cotrimoxazole ne doit pas être admimistré immédiatement après une vaccination antitétanique, car il y a risque de ?",
    img: "",
    responses: [
      "Aplasie médullaire",
      "Troubles cochléaire",
      "Colite pseudo membraneuse",
      "Immunodépression",
      "Hépatite cholestatique."
    ],
    correct: 3
  },
  {
    question: "Parmi les macrolides suivants, indiquer celui qui n’a pas d’action inhibitrice enzymatique ?",
    img: "",
    responses: [
      "Spiramycine",
      "Clarithromycine",
      "Erythromycine",
      "Azithromycine",
      "Roxithromycine."
    ],
    correct: 0
  },
  {
    question: "Parmi les macrolides suivants, indiquer celui qui a une particularité d’accidents auditifs ?",
    img: "",
    responses: [
      "Azithromycine",
      "Roxithromycine",
      "Erythromycine",
      "Spiramycine",
      "Clarithromycine"
    ],
    correct: 4
  },
  {
    question: "Parmi les macrolides suivants, indiquer celui qui est la plus longue durée d’action ?",
    img: "",
    responses: [
      "Erythromycine",
      "Roxithromycine",
      "Azithromycine",
      "Clarithromycine",
      "Spiramycine."
    ],
    correct: 2
  },
  {
    question: "Parmi les antibiotiques suivants, celui qui est actif dans la pneumonie à pneumocystis carinii ?",
    img: "",
    responses: [
      "Pénicilline M",
      "Sulfamide + Triméthoprim",
      "Amikacine",
      "Minocycline",
      "Gentamycine."
    ],
    correct: 1
  },
  {
    question: "Parmi les associations antibiotiques ci-dessous, indiquer celui qui est contre indiquer ?",
    img: "",
    responses: [
      "Tétracycline + Gentalline",
      "Gentamycine + Pénicilline M",
      "Doxycycline + Azithromycine",
      "Clindamycine + Erythromycine",
      "Métronidazole + Lincomycine."
    ],
    correct: 3
  },
  {
    question: "A quelle famille d’antibiotiques appartient la framycétine (Soframycine*) ?",
    img: "",
    responses: [
      "Les sulfamides",
      "Les cyclines",
      "Les aminosides",
      "Les quinolones",
      "Les bêta-lactamines."
    ],
    correct: 2
  },
  {
    question: "L’ototoxicité (VIIIème paire) est un accident caractéristique d’une atibiotique, laquelle ?",
    img: "",
    responses: [
      "Gentalline",
      "Colistine",
      "Céphalosporine",
      "Tétracycline",
      "Polymyxine."
    ],
    correct: 0
  },
  {
    question: "Quel est l’antibiotique de choix dans le traitement de la nocardiose chez des sujets immunodéprimés ?",
    img: "",
    responses: [
      "Cotrimoxazole",
      "Gentalline",
      "Terramycine",
      "Spiramycine",
      "Céphalosporine."
    ],
    correct: 0
  },
  {
    question: "Parmi les antibiotiques suivants, quel est celui qui a la meilleure diffusion dans le LCR ?",
    img: "",
    responses: [
      "Staphylomycine",
      "Céphalosporine 1ère génération",
      "Céphalosporine 2ème génération",
      "Céphalosporine 3ème génération",
      "Groupes aminosidiques"
    ],
    correct: 3
  },
  {
    question: "Un des antibiotiques suivants est particulièrement indiqué dans les infections par le BK. Laquelle ?",
    img: "",
    responses: [
      "Doxycycline",
      "Céphalosporine",
      "Rifampicine",
      "Carbénicilline",
      "Trobicine"
    ],
    correct: 2
  },
  {
    question: "Parmi les antibiotiques cités ci-dessous, lequel qui n’est jamais actif sur les bacilles pyocyaniques ?",
    img: "",
    responses: [
      "Colistine (Colimycine*)",
      "Polymycine .B",
      "Carbénicilline",
      "Céfotaxime",
      "Ampicilline"
    ],
    correct: 4
  },
  {
    question: "Parmi les propositions suivantes, laquelle s’applique le mieux méthicilline ?",
    img: "",
    responses: [
      "Spectre large, réservé au traitement des infections à P. aerusginosa",
      "Spectre large, détruit par la pénicillinase du staphylocoque",
      "Spectre étroit, résistant à la pénicillinase du staphylocoque",
      "Spectre moyen, sensible à la pénicillinase du staphylocoque",
      "Spectre très large, résistant à la pénicillinase du staphylocoque."
    ],
    correct: 2
  },
  {
    question: "Parmi les atibiotiques suivants, indiquer celui qui ne possède pas d’activité antistaphylococcique ?",
    img: "",
    responses: [
      "Ampiciline",
      "Céphalosporine de 1ère génération",
      "Péfloxacine",
      "Pristinamycine (Pyostacine*)",
      "Acide fusidique (Fucidine*)."
    ],
    correct: 0
  },
  {
    question: "La spécialité CLAVENTIN = Ticarcilline+acide clavulanique. Cette association réalise ?",
    img: "",
    responses: [
      "Une synergie additive d’effets",
      "Un antagonisme correcteur d’effets toxiques",
      "Une augmentation des concentrations plasmatiques d’ampicilline",
      "Un élargissement du spectre antibactérien",
      "Un renforcement d’efficacité par inhibition des bêtalactamases bactériennes"
    ],
    correct: 4
  },
  {
    question: "Un seul des antibiotiques peut être utilisé à n’importe quelle période de la grossesse. Lequel ?",
    img: "",
    responses: [
      "Acide nalidixique",
      "Cotrimoxazole",
      "Pénicilline G",
      "Sulfamides",
      "Tétracyclines."
    ],
    correct: 2
  },
  {
    question: "Un médicament dont la demi-vie est de 6 heures. Au bout de combien de temps la concentration plasmatique de ce médicament soit pratiquement nulle après l’arrêt du traitement ?",
    img: "",
    responses: [
      "Un jour",
      "30 heures",
      "deux jours",
      "72 heures",
      "quatre jours."
    ],
    correct: 1
  },
  {
    question: "Enfin de traitement d’une maladie infection bactérienne, le patient étant guéri, quelle est la modalité d’arrêt de l’antibiothérapie ?",
    img: "",
    responses: [
      "Réduction progressive des doses",
      "Arrêt brutal",
      "Administration discontinue un jour sur deux",
      "Réduction du nombre de prises quotidiennes",
      "Augmentation de la posologie dans les derniers jours."
    ],
    correct: 1
  },
  {
    question: "La pénicilline G est régulièrement active sur ?",
    img: "",
    responses: [
      "Streptocoque du groupe .A",
      "Bacilles .G ( - )",
      ".P. aeruginosa",
      "Mycoplasma pneumoniae",
      "Hémophilus influenzae"
    ],
    correct: 0
  },
  {
    question: "Un adolescent présent une angine rouge suspecte d’origine streptococcique (groupe A) quel antibiotique le plus mieux adapté ?",
    img: "",
    responses: [
      "Erythromycines",
      "Gentamycine",
      "Cefiximes",
      "Sulfamides",
      "Ciprofloxacine."
    ],
    correct: 0
  },
  {
    question: "Prescrits par voie générale certains atibiotiques ne traversent pas ou mal la barrière hémato méningée en cas de méningite et sont donc contre-indiqués. Quel est le plus mieux traversé dans le LCR ?",
    img: "",
    responses: [
      "Ampicilline (Totapene*)",
      "Pristinamycine (Pyostacine*)",
      "Vancomycie",
      "Spiramycine (Rovamycine*)",
      "Aminosides"
    ],
    correct: 0
  },
  {
    question: "Les propositions ci-dessous associent un antibiotique et un effet toxique lequel est incorrecte ?",
    img: "",
    responses: [
      "Ciprofloxacine-tendinopathie",
      "Gentamycine-insuffisance rénale",
      "Colistine-hépatite",
      "Vancomycine-insuffisance rénale",
      "Clindamycine- rétinite"
    ],
    correct: 4
  },
  {
    question: "Parmi les antibiotiques ci-dessous, indiquer celui qui est inactif dans tous les cas contre les staphylocoques sécréteurs de pénicillinase ?",
    img: "",
    responses: [
      "Méthicilline (Flabelline*)",
      "Ampicilline",
      "Vancomycine (Vancocine*)",
      "Erythromycine",
      "Sisomycine (Sisolline*)"
    ],
    correct: 1
  },
  {
    question: "Parmi les antécédents suivants quel est contre-indiqué de prescrire par Quinolone 3ème génération ?",
    img: "",
    responses: [
      "Insuffisance cardiaque",
      "Insuffisance hépatique",
      "Convulsion",
      "Ulcère gastrique",
      "Infection à VIH."
    ],
    correct: 0
  },
  {
    question: "What is the mechanism of action of morphine?",
    img: "",
    responses: [
      "Acting through binding on G protein couple receptor",
      "Acting through binding on enzyme adenylate cyclase",
      "Acting through binding on exchanger Na⁺ – Ca⁺⁺",
      "Acting through binding on tyrosine kinase coupled receptor",
      "Acting through binding on potassium channel"
    ],
    correct: 0
  },
  {
    question: "What second messenger involved in mechanism of action of morphine?",
    img: "",
    responses: [
      "cAMP",
      "cGMP",
      "DAG",
      "IP3",
      "Calmodulin"
    ],
    correct: 0
  },
  {
    question: "What is the effect of AVP on V1 receptor?",
    img: "",
    responses: [
      "Vasoconstriction",
      "ACTH releasing",
      "Reabsorption of water",
      "Reabsorption of Na⁺ – Cl⁻",
      "Inhibition post-synaptic potential"
    ],
    correct: 0
  },
  {
    question: "What is the effect of AVP on V2 receptor?",
    img: "",
    responses: [
      "Vasoconstriction",
      "ACTH releasing",
      "Reabsorption of water",
      "Reabsorption of Na⁺ – Cl⁻",
      "Activation post-synaptic potential"
    ],
    correct: 2
  },
  {
    question: "Digoxin acts on what of the following transporters?",
    img: "",
    responses: [
      "Na⁺ – K⁺ ATPases pump",
      "H⁺ – K⁺ ATPases pump",
      "Co-transport Na⁺ – K⁺ – 2Cl⁻",
      "Na⁺ – Ca⁺⁺ exchanger",
      "Co-transport Na⁺ – Cl⁻"
    ],
    correct: 0
  },
  {
    question: "Digoxin achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 0
  },
  {
    question: "Omeprazole acts on what of the following transporters?",
    img: "",
    responses: [
      "Na⁺ – K⁺ ATPases pump",
      "H⁺ – K⁺ ATPases pump",
      "Co-transport Na⁺ – K⁺ – 2Cl⁻",
      "Na⁺ – Ca⁺⁺ exchanger",
      "Co-transport Na⁺ – Cl⁻"
    ],
    correct: 1
  },
  {
    question: "Omeprazole achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 0
  },
  {
    question: "THIAZIDES acts on what of the following transporters?",
    img: "",
    responses: [
      "Na⁺ – K⁺ ATPases pump",
      "H⁺ – K⁺ ATPases pump",
      "Na⁺ – Ca⁺⁺ exchanger",
      "HCO3- – Cl⁻ exchanger",
      "Co-transport Na⁺ – Cl⁻"
    ],
    correct: 4
  },
  {
    question: "Loop diuretics achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 1
  },
  {
    question: "Furosemide acts on what of the following transporters?",
    img: "",
    responses: [
      "H⁺ – K⁺ ATPases pump",
      "Na⁺ – K⁺ ATPases pump",
      "Co-transport Na⁺ – K⁺ – 2Cl⁻",
      "Na⁺ – Ca⁺⁺ exchanger",
      "Co-transport Na⁺ – Cl⁻"
    ],
    correct: 1
  },
  {
    question: "Amlodipine (CCB) achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 2
  },
  {
    question: "Amlodipine acts on what of the following transporters?",
    img: "",
    responses: [
      "L-type voltage calcium channel",
      "T-type voltage calcium Channel",
      "K⁺ dependent calcium channel",
      "Ca⁺⁺ ATPases pump",
      "Na⁺ – Ca⁺⁺ exchanger"
    ],
    correct: 0
  },
  {
    question: "Amiloride acts on what of the following transporters?",
    img: "",
    responses: [
      "Na⁺ – K⁺ ATPases pump",
      "Na⁺ – Ca⁺⁺ exchanger",
      "HCO3- – Cl⁻ exchanger",
      "Renal outer medullary K⁺ channel (ROMK)",
      "Epithelial Na⁺ channel (ENaC)"
    ],
    correct: 4
  },
  {
    question: "Triamterene acts on what of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Cation exchange",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 2
  },
  {
    question: "Aldosterone achieves its effect through what mechanism?",
    img: "",
    responses: [
      "Binding to intracellular receptor of principle cell of renal tubule",
      "Activating Na⁺ – K⁺ channels",
      "Activating carbonic anhydrase",
      "Inhibiting converting enzyme",
      "Producing sodium – glucose transporter 2"
    ],
    correct: 0
  },
  {
    question: "Effect of aspirin acts through what mechanism?",
    img: "",
    responses: [
      "Inhibiting COX1 and COX2",
      "Inhibiting ACE",
      "Opening K⁺ channels for hyperpolarization",
      "Binding to ionotropic receptor of Na+ channel",
      "Binding to metabotropic receptor"
    ],
    correct: 0
  },
  {
    question: "Aspirin acts on what of the following enzymes?",
    img: "",
    responses: [
      "Cyclooxygenase",
      "Phosphodiesterase",
      "Converting enzyme",
      "Carbonic anhydrase",
      "Phospholipase"
    ],
    correct: 0
  },
  {
    question: "Sildenafil acts trough what mechanism?",
    img: "",
    responses: [
      "Activating Carbonic anhydrase",
      "Activating aromatase",
      "Inhibiting PDE5",
      "Inhibiting cholinesterase",
      "Inhibiting LOX"
    ],
    correct: 2
  },
  {
    question: "Theophylline acts trough what mechanism?",
    img: "",
    responses: [
      "Inhibiting COX1 and COX2",
      "Inhibiting 5α reductase",
      "Inhibiting PDE 3",
      "Inhibiting cholinesterase",
      "Activating LOX"
    ],
    correct: 2
  },
  {
    question: "Physostigmine act on what enzyme?",
    img: "",
    responses: [
      "Cholinesterase",
      "Lipoxygenase",
      "Cyclooxygenases",
      "Aromatase",
      "Reductase"
    ],
    correct: 0
  },
  {
    question: "Finasteride act on what enzyme?",
    img: "",
    responses: [
      "Cholinesterase",
      "Lipoxygenase",
      "Cyclooxygenases",
      "Aromatase",
      "Reductase"
    ],
    correct: 4
  },
  {
    question: "Exemestane act on what enzyme?",
    img: "",
    responses: [
      "Carbonic anhydrase",
      "Phospholipase",
      "Cyclooxygenases",
      "Aromatase",
      "Reductase"
    ],
    correct: 3
  },
  {
    question: "Calcium channel blocker acts through what mechanism?",
    img: "",
    responses: [
      "Block Na⁺ – Ca⁺⁺ exchanger",
      "Block voltage dependent calcium channel",
      "Block Ca⁺⁺ ATPase pump",
      "Block calcium dependent potassium channel",
      "Activate inactive gate of calcium channel"
    ],
    correct: 1
  },
  {
    question: "What is the constant of dissociation of a drug Kd from its target?",
    img: "",
    responses: [
      "Kd = Koff/Kon",
      "Kd = Kon/Koff",
      "Kd = Kon + Koff",
      "Kd = Kon – Koff",
      "Kd = Koff – Kon"
    ],
    correct: 0
  },
  {
    question: "What quality of drug is to be said high affinity to its target?",
    img: "",
    responses: [
      "rate of dissociation [Kd] is low",
      "rate of dissociation [Kd] is medium",
      "rate of dissociation [Kd] is high",
      "rate of dissociation [Kd] is very high",
      "rate of dissociation [Kd] is indefinite"
    ],
    correct: 0
  },
  {
    question: "Owing to Kd = dissociation constant; R₀ = Total receptor. Formulate law mass action indicating the interaction between Drug – Receptor (D – R)",
    img: "",
    responses: [
      "D-R = ([R₀] x [D]) + ([D] + Kd)",
      "D-R = ([R₀] x [D]) x ([D] + Kd)",
      "D-R = ([R₀] x [D]) - ([D] + Kd)",
      "D-R = ([R₀] x [D]) / ([D] + Kd)",
      "D-R = ([R₀] + [D]) / ([D] x Kd)"
    ],
    correct: 3
  },
  {
    question: "What is the signification of dissociation constant Kd?",
    img: "",
    responses: [
      "Concentration of drug capable of binding 50% of the total receptors",
      "Concentration of drug capable of binding 100% of the total receptors",
      "Concentration of drug capable of dissociate from receptors by 20%",
      "Concentration of drug capable of dissociate from receptors by 80%",
      "Concentration of drug capable of dissociate totally from receptors"
    ],
    correct: 0
  },
  {
    question: "Which of the following formula is correct concerning affinity of drug (Kd = dissociation constant)?",
    img: "",
    responses: [
      "Affinity of a drug = 1/Kd",
      "Affinity of a drug = Kd/1",
      "Affinity of a drug = 1 x Kd",
      "Affinity of a drug = 1 + Kd",
      "Affinity of a drug = Kd – 1"
    ],
    correct: 0
  },
  {
    question: "What is the meaning of EC50?",
    img: "",
    responses: [
      "Drug concentration gives rise to efficacity 50%",
      "Drug concentration gives rise to efficacity maximum",
      "Drug concentration gives rise to efficacity optimum",
      "Drug concentration gives rise to efficacity in one half life",
      "One half-life gives rise to efficacy 50%"
    ],
    correct: 0
  },
  {
    question: "What properties of a drug is to be said full agonist?",
    img: "",
    responses: [
      "Affinity to receptor with inverse response",
      "Affinity to receptor with no response",
      "Affinity to receptor with submaximal response",
      "Low affinity to receptor with no response",
      "Affinity to receptor with high maximal response"
    ],
    correct: 4
  },
  {
    question: "What properties of a drug is to be said antagonist?",
    img: "",
    responses: [
      "Affinity to receptor with maximal response",
      "High affinity to receptor with no response",
      "Affinity to receptor with submaximal response",
      "Low affinity to receptor with no response",
      "Low affinity to receptor with high response"
    ],
    correct: 1
  },
  {
    question: "What properties of a drug is to be said inverse agonist?",
    img: "",
    responses: [
      "Low affinity to receptor with maximal response",
      "High affinity to receptor with no response",
      "High affinity to receptor with submaximal response",
      "Low affinity to receptor with no response",
      "Affinity to receptor with inverse response"
    ],
    correct: 4
  },
  {
    question: "When partial agonist drug is given with full agonist drug, what is the dynamic interaction as a result?",
    img: "",
    responses: [
      "synergic",
      "additive",
      "competitive",
      "inverse",
      "permissive"
    ],
    correct: 2
  },
  {
    question: "What is the property of a drug with full agonist and low potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal",
      "EC50 high + response inverse"
    ],
    correct: 0
  },
  {
    question: "What is the property of a drug with full agonist and high potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal",
      "EC50 low + response inverse"
    ],
    correct: 1
  },
  {
    question: "What is the property of a drug with partial agonist but high potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal"
    ],
    correct: 3
  },
  {
    question: "What is the property of a drug with full agonist but low potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal"
    ],
    correct: 0
  },
  {
    question: "Define inverse agonist",
    img: "",
    responses: [
      "affinity to receptor with maximal response",
      "affinity to receptor with inverse response",
      "affinity to receptor with no response",
      "affinity to receptor with partial response",
      "No affinity to receptor with inverse response"
    ],
    correct: 1
  },
  {
    question: "Aspirin is a weak acid with pK3. What pH in the stomach Aspirin would be absorbed 50%?",
    img: "",
    responses: [
      "1",
      "2",
      "3",
      "4",
      "5"
    ],
    correct: 2
  },
  {
    question: "Aspirin is a weak acid with pK3. What pH in the stomach Aspirin would be highly absorbed?",
    img: "",
    responses: [
      "1",
      "2",
      "3",
      "4",
      "5"
    ],
    correct: 0
  },
  {
    question: "Amphetamine is weak base with pK3. What pH in the intestine, it would be absorbed 50%?",
    img: "",
    responses: [
      "1",
      "2",
      "3",
      "4",
      "5"
    ],
    correct: 2
  },
  {
    question: "Amphetamine is weak base with pK3. What pH in the intestine, it would be highly absorbed?",
    img: "",
    responses: [
      "2",
      "3",
      "4",
      "5",
      "6"
    ],
    correct: 4
  },
  {
    question: "What is the distribution volume of a drug given 500mg iv with its plasma concentration 25mg/L at steady state?",
    img: "",
    responses: [
      "5L",
      "10L",
      "15L",
      "20L",
      "30L"
    ],
    correct: 3
  },
  {
    question: "What is the loading dose of a drug with volume distribution 20L and its plasma concentration required at steady state is 25 mg/L?",
    img: "",
    responses: [
      "200 mg",
      "400 mg",
      "500 mg",
      "600 mg",
      "800 mg"
    ],
    correct: 2
  },
  {
    question: "What is the property of a drug with large volume distribution?",
    img: "",
    responses: [
      "Macromolecule",
      "High affinity to serum albumin",
      "Hydrophilic",
      "Lipophilic",
      "Amphoteric"
    ],
    correct: 3
  },
  {
    question: "What is the property of a drug with small volume distribution?",
    img: "",
    responses: [
      "Macromolecule",
      "High affinity to serum albumin",
      "Hydrophilic",
      "Lipophilic",
      "Amphoteric"
    ],
    correct: 1
  },
  {
    question: "What pathway of administration of drug result in bioavailability 100%?",
    img: "",
    responses: [
      "IV",
      "IM",
      "PO",
      "Subcutaneous",
      "Inhalation"
    ],
    correct: 0
  },
  {
    question: "What is the formula for bioavailability of drug? AUC area under curve",
    img: "",
    responses: [
      "AUC iv/AUC po x 100",
      "AUC po/AUC iv x 100",
      "AUC po/AUC iv /100",
      "AUC iv/AUC po/100",
      "AUC po/AUC iv + 100"
    ],
    correct: 1
  },
  {
    question: "Which of the following metabolisms is used in biotransformation (phase 1) in the liver?",
    img: "",
    responses: [
      "Sulfation",
      "Acetylation",
      "Glucuronidation",
      "Hydrolysis",
      "Methylation"
    ],
    correct: 3
  },
  {
    question: "Which of the following metabolisms is used to conjugate (phase 2) a metabolite in the liver?",
    img: "",
    responses: [
      "Oxidation",
      "Hydroxylation",
      "Hydrolysis",
      "Acetylation",
      "Deamination"
    ],
    correct: 3
  },
  {
    question: "Which drug is excreted with zero order kinetic?",
    img: "",
    responses: [
      "acetaminophen",
      "aspirin",
      "rifampicin",
      "cimetidine",
      "atropine"
    ],
    correct: 1
  },
  {
    question: "Which drug is excreted with zero order kinetic?",
    img: "",
    responses: [
      "acetaminophen",
      "alcohol",
      "rifampicin",
      "cimetidine",
      "atropine"
    ],
    correct: 1
  },
  {
    question: "What is the formula of plasma centration of drug at any time (CT) during elimination? C₀: initial concentration; Ke constant of elimination; T: time",
    img: "",
    responses: [
      "CT = C₀.e⁻ᴷᵉᵀ",
      "CT = C₀ xᴷᵉᵀ",
      "CT = C₀ /ᴷᵉᵀ",
      "CT = C₀ –ᴷᵉᵀ",
      "CT = C₀ +ᴷᵉᵀ"
    ],
    correct: 0
  },
  {
    question: "Formulate half-life T1/2 related to rate of elimination Ke?",
    img: "",
    responses: [
      "T1/2=ln2/Ke",
      "T1/2=ln2 x Ke",
      "T1/2 = Ke/ln2",
      "T1/2= ln2 + Ke",
      "T1/2= ln2 – Ke"
    ],
    correct: 0
  },
  {
    question: "Relate elimination constant (Ke) to clearance (CL) and distribution volume (Vd) of drug?",
    img: "",
    responses: [
      "Ke = CL/Vd",
      "Ke = Vd/CL",
      "Ke = Vd + CL",
      "Ke = Vd x CL",
      "Ke = Vd – CL"
    ],
    correct: 0
  },
  {
    question: "What is the haft life of a drug with constant elimination Ke 1/10?",
    img: "",
    responses: [
      "4h",
      "5h",
      "7h",
      "8h",
      "10h"
    ],
    correct: 2
  },
  {
    question: "How many haft lives of drug we administrate to get its plasma concentration at steady state?",
    img: "",
    responses: [
      "2",
      "3",
      "4",
      "5",
      "6"
    ],
    correct: 3
  },
  {
    question: "How many haft lives of drug the kidney should clear it totally from the body?",
    img: "",
    responses: [
      "2",
      "3",
      "4",
      "5",
      "6"
    ],
    correct: 3
  },
  {
    question: "Give the equation for maintenance dose?",
    img: "",
    responses: [
      "D = distribution volume x effective plasma concentration",
      "D = Clearance x effective plasma concentration",
      "D = Clearance/effective plasma concentration",
      "D = distribution volume /effective plasma concentration",
      "D = distribution volume + effective plasma concentration"
    ],
    correct: 1
  },
  {
    question: "Interaction of Tetracycline with Aluminum is done through what process?",
    img: "",
    responses: [
      "Inactivating P glycoprotein",
      "chelation",
      "deconjugation",
      "competition for organic anion transport",
      "competition for organic cation transport"
    ],
    correct: 1
  },
  {
    question: "Interaction of probenecid administrated with cephalosporin is done through what process?",
    img: "",
    responses: [
      "Inactivating P glycoprotein",
      "Activating Cytochrome P450",
      "Displacing from Albumin",
      "Competition for organic Anion Transporter",
      "Competition for Agonic site of receptor"
    ],
    correct: 3
  },
  {
    question: "Interaction of Digoxin combined with Quinidine is done through what process?",
    img: "",
    responses: [
      "Inactivating P glycoprotein",
      "Activating Cytochrome P450",
      "Displacing from Albumin",
      "Competition for organic Anion Transporter",
      "Binding to Allosteric site of receptor"
    ],
    correct: 0
  },
  {
    question: "What is the management to avoid interaction of rifampicin with warfarin?",
    img: "",
    responses: [
      "give one drugs on hour before another",
      "adjust dose of affected drug after INR",
      "decrease dose of precipitant drug",
      "avoid concurrent therapy",
      "Change formula of one drug"
    ],
    correct: 1
  },
  {
    question: "Interaction of Warfarin combined with cimetidine is done through what process?",
    img: "",
    responses: [
      "Activating P glycoprotein",
      "Inactivating Cytochrome P450",
      "Displacing from Albumin",
      "Competition for organic Anion Transporter",
      "Binding to Allosteric site of receptor"
    ],
    correct: 1
  },
  {
    question: "What is the effect of NSAID + Warfarin?",
    img: "",
    responses: [
      "hyper coagulation",
      "hypo coagulation",
      "increased inflammation",
      "decreased inflammation",
      "thrombocytopenia"
    ],
    correct: 1
  },
  {
    question: "What is the management to interaction of interaction cimetidine – warfarin?",
    img: "",
    responses: [
      "increase dose of warfarin",
      "checkup INR",
      "give another anti secretion acid",
      "avoid concurrent therapy",
      "decrease dose of cimetidine"
    ],
    correct: 2
  },
  {
    question: "What combination should be avoided in a patient with ischemic heart disease?",
    img: "",
    responses: [
      "sildenafil + nitrate",
      "sildenafil + β blocker",
      "Prostaglandin + nitrate",
      "Prostaglandin +β blocker",
      "CCB + β blocker"
    ],
    correct: 0
  },
  {
    question: "What cause the adverse effect of fat-soluble drug in elderly person?",
    img: "",
    responses: [
      "slow gastric emptying",
      "decreased volume distribution",
      "increased volume distribution",
      "increased hepatic clearance",
      "increased renal clearance"
    ],
    correct: 2
  },
  {
    question: "What cause the adverse effect of water-soluble drug in elderly person?",
    img: "",
    responses: [
      "slow gastric emptying",
      "decreased volume distribution",
      "increased volume distribution",
      "increased hepatic clearance",
      "increased renal clearance"
    ],
    correct: 1
  },
  {
    question: "What metabolic pathway of drug is preferred to the elderly person?",
    img: "",
    responses: [
      "reduction",
      "oxidation",
      "alkylation",
      "glucuronidation",
      "acetylation"
    ],
    correct: 3
  },
  {
    question: "Define mutation",
    img: "",
    responses: [
      "order sequence of A-G-T-C",
      "change in the base sequence",
      "Transcription error of the base sequence",
      "Translation error of the messenger RNA",
      "Degeneration of protein"
    ],
    correct: 1
  },
  {
    question: "Define Gene",
    img: "",
    responses: [
      "order sequence of A-G-T-C",
      "change in the base sequence",
      "Transcription error of the base sequence",
      "Translation error of the messenger RNA",
      "Degeneration of protein"
    ],
    correct: 0
  },
  {
    question: "Define polymorphism",
    img: "",
    responses: [
      "order of the base sequence",
      "change in the base sequence",
      "alternative of the base sequence",
      "multiple of messenger RNA",
      "repeated base sequence"
    ],
    correct: 2
  },
  {
    question: "What are the components of base sequence?",
    img: "",
    responses: [
      "A – G – T – C",
      "A – B – C – D",
      "G – H – I – J",
      "T – U – V – X",
      "C – D – E – F"
    ],
    correct: 0
  },
  {
    question: "What is single nucleotide polymorphism?",
    img: "",
    responses: [
      "substitution of one nucleotide for another",
      "change the sequence of nucleotides",
      "loss one nucleotide",
      "gain one nucleotide",
      "repeated of one nucleotide"
    ],
    correct: 0
  },
  {
    question: "What is the common substitution of nucleotide in polymorphism?",
    img: "",
    responses: [
      "C for T",
      "G for A",
      "T for C",
      "A for G",
      "G for T"
    ],
    correct: 0
  },
  {
    question: "What is the result of polymorphism for an individual to response to a drug?",
    img: "",
    responses: [
      "same drug with same response in different individuals",
      "same drug with different responses in an individual",
      "same drug with different responses in different individuals",
      "different drugs have the same response in an individual",
      "different drugs have different response in different individuals"
    ],
    correct: 2
  },
  {
    question: "Poor acetylation may alter metabolism of what drugs?",
    img: "",
    responses: [
      "INH",
      "Steroid",
      "Aspirin",
      "Acetaminophen",
      "Rifampicin"
    ],
    correct: 0
  },
  {
    question: "Poor acetylation may alter metabolism of what drugs?",
    img: "",
    responses: [
      "phenytoin",
      "Steroid",
      "Aspirin",
      "Acetaminophen",
      "Rifampicin"
    ],
    correct: 0
  },
  {
    question: "Poor acetylation may alter metabolism of what drugs?",
    img: "",
    responses: [
      "hydralazine",
      "Steroid",
      "Aspirin",
      "Acetaminophen",
      "Rifampicin"
    ],
    correct: 0
  },
  {
    question: "Poor metabolism to convert codeine to morphine require how dose of codeine?",
    img: "",
    responses: [
      "higher",
      "normal",
      "normal low",
      "normal high",
      "lower"
    ],
    correct: 0
  },
  {
    question: "Explain what mitochondria DNA mutation give rise to gentamycin ototoxicity?",
    img: "",
    responses: [
      "hair cells sharing properties with bacteria ribosome",
      "increased plasma level of gentamycin",
      "decreased excretion of gentamycin",
      "alteration of gentamycin metabolism",
      "low affinity to gentamycin"
    ],
    correct: 0
  },
  {
    question: "What polymorphism gene that relate to affinity of warfarin?",
    img: "",
    responses: [
      "CYP2C9",
      "VKORC1",
      "CYP2D6",
      "CYP3A4",
      "CYP2D7"
    ],
    correct: 1
  },
  {
    question: "What polymorphism gene that relate to warfarin metabolism?",
    img: "",
    responses: [
      "CYP2C9",
      "VKORC1",
      "CYP2D6",
      "CYP2D7",
      "CYP3A4"
    ],
    correct: 0
  },
  {
    question: "What polymorphism gene that relate to tamoxifen metabolism?",
    img: "",
    responses: [
      "CYP2C9",
      "VKORC1",
      "CYP2D6",
      "CYP3A4",
      "HLAB*5701"
    ],
    correct: 0
  },
  {
    question: "What HLA gene that related to susceptibility of abacavir?",
    img: "",
    responses: [
      "HLAB*5701",
      "HLA*1502",
      "HLA-DQB10*201",
      "HLA-DQB*05",
      "HLA-DBQ*06"
    ],
    correct: 0
  },
  {
    question: "What HLA gene that related to Stevens Johnson syndrome with carbamazepine?",
    img: "",
    responses: [
      "HLAB*5701",
      "HLA*1502",
      "HLA-DQB1*0201",
      "HLA-DQB*05",
      "HLA-DBQ*06"
    ],
    correct: 1
  },
  {
    question: "What HLA gene that related to agranulocytosis with carbamazepine?",
    img: "",
    responses: [
      "HLAB*5701",
      "HLA*1502",
      "HLA-DQB1*0201",
      "HLA-DQB*05",
      "HLA-DBQ*06"
    ],
    correct: 2
  },
  {
    question: "What Enzyme deficiency related to gene mutation → bone toxicity by thiopurines?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 1
  },
  {
    question: "What Enzyme deficiency due to gene mutation → interaction thiopurine with allopurinol?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 2
  },
  {
    question: "What Enzyme deficiency related to gene mutation → hemolysis?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 3
  },
  {
    question: "What Enzyme detoxify 5FU?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 0
  },
  {
    question: "What cytochrome involved in interaction of warfarin and phenobarbital?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2D6",
      "CYP3A4",
      "CYP3A5",
      "CYP2D7"
    ],
    correct: 0
  },
  {
    question: "What cytochrome involved in interaction of erythromycin and phenobarbital?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2C10",
      "CYP2D6",
      "CYP2D7",
      "CYP3A4/5"
    ],
    correct: 4
  },
  {
    question: "What cytochrome involved in interaction of verapamil and rifampicin?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2C10",
      "CYP2D6",
      "CYP2D7",
      "CYP3A4/5"
    ],
    correct: 4
  },
  {
    question: "What cytochrome involved in metabolism of imipramine?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2C10",
      "CYP2D7",
      "CYP2D6",
      "CYP3A4/5"
    ],
    correct: 3
  }








    
    ],
    memoriesList: [], // Stores indices of questions from the main bank
    testQuestions: [],
    answers: [],
    currentTestConfig: {},
    idx: 0,
    quizTitle: "Multiple Choice Question Preparation",
    editIdx: -1,
    editQ: null,
    isMuted: true,
    dark: window.matchMedia && window.matchMedia('(prefers-color-scheme: dark)').matches,
    timerId: null,
  };
}
let state = getDefaultState();

// --- Utility & Data Functions ---
function saveData() {
  localStorage.setItem(MEMORY_LIST_KEY, JSON.stringify(state.memoriesList));
}
function loadData() {
  try {
    const memoryData = JSON.parse(localStorage.getItem(MEMORY_LIST_KEY));
    if (memoryData) {
      state.memoriesList = memoryData;
    }
    const settings = JSON.parse(localStorage.getItem(SETTINGS_KEY));
    if (settings) {
        state.dark = settings.dark || false;
        state.isMuted = settings.isMuted === undefined ? true : settings.isMuted;
    }
  } catch (e) {
    console.error("Failed to load data from localStorage", e);
  }
}
function saveSettings() {
    localStorage.setItem(SETTINGS_KEY, JSON.stringify({ dark: state.dark, isMuted: state.isMuted }));
}
function shuffle(arr) {
  const a = arr.slice();
  for(let i = a.length - 1; i > 0; i--) {
    const j = Math.floor(Math.random() * (i + 1));
    [a[i], a[j]] = [a[j], a[i]];
  }
  return a;
}
function escapeHtml(str) {
    if (typeof str !== 'string') return '';
    const brPlaceholder = '___BR___';
    let tempStr = str.replace(/<br\s*\/?>/gi, brPlaceholder);
    tempStr = tempStr.replace(/[&<>"']/g, t => ({
        '&': '&amp;', '<': '&lt;', '>': '&gt;', '"': '&quot;', "'": '&#39;'
    }[t]));
    return tempStr.replace(new RegExp(brPlaceholder, 'g'), '<br>');
}
function getScoreRemark(score) {
  if (score === 100) return "Perfect Score! You are a genius! 🧠";
  if (score >= 90) return "Excellent work! You really know your stuff. ✨";
  if (score >= 80) return "Great job! Very impressive. 👍";
  if (score >= 70) return "Good score! Keep up the good work. 😊";
  if (score >= 50) return "Not bad, but there's room for improvement. Keep studying! 📚";
  if (score >= 30) return "You've got the basics, but review is needed. Don't give up! 💪";
  return "This was a tough one. Review your mistakes and try again! 🤔";
}

// --- Audio Controls ---
function setupAudio() {
    const audio = document.getElementById('bg-music');
    if (musicBase64 && musicBase64.includes('data:audio')) {
      audio.src = musicBase64;
    }
    audio.muted = state.isMuted;
    if (!state.isMuted) {
      audio.play().catch(e => console.log("Autoplay was prevented."));
    }
}
window.toggleMute = function() {
    state.isMuted = !state.isMuted;
    const audio = document.getElementById('bg-music');
    audio.muted = state.isMuted;
    if (!state.isMuted) {
        audio.play().catch(e => console.log("Could not play audio."));
    } else {
        audio.pause();
    }
    saveSettings();
    render();
}
window.toggleDarkMode = function() {
    state.dark = !state.dark;
    saveSettings();
    render();
}


// --- Core Rendering Engine ---
function render() {
  document.body.className = state.dark ? "dark" : "";
  const app = document.getElementById("app");
  app.innerHTML = ''; // Clear previous content

  switch (state.view) {
    case "menu": renderMenu(app); break;
    case "view_bank": renderViewBank(app); break;
    case "memories_list": renderMemoriesList(app); break;
    case "study_setup": renderRangeSetup(app, 'study'); break;
    case "study_test": renderFullTest(app); break;
    case "test_setup": renderRangeSetup(app, 'test'); break;
    case "test_test": renderFullTest(app); break; // Reuses study test view
    case "sixty_setup": renderSixtySetup(app); break;
    case "paged_test": renderPagedTest(app); break; // For 60/60, time limit, memory tests
    case "timelimit_setup": renderTimeLimitSetup(app); break;
    case "memories_setup": renderMemoriesSetup(app); break;
    case "results": renderResults(app); break;
    case "instruction": renderInstruction(app); break;
    case "edit_question": renderEdit(app); break;
    default: app.innerHTML = "<h2>Unknown Page</h2>"; break;
  }
}
function renderHeader(title) {
    return `
    <div class="global-header">
      <button class="btn-secondary" onclick="setView('menu')">‹ Back to Main Menu</button>
      <div class="header-icons">
        <button class="icon-btn" onclick="toggleMute()">${state.isMuted ? '🔇' : '🔊'}</button>
        <button class="icon-btn" onclick="toggleDarkMode()">${state.dark ? "☀️" : "🌙"}</button>
      </div>
    </div>
    <h1>${escapeHtml(title)}</h1>
  `;
}

// --- View-Specific Renderers ---
function renderMenu(app) {
 app.innerHTML = `
    <div class="global-header">
      <h1 style="margin: 0;" contenteditable="true" onblur="updateTitle(this)">${escapeHtml(state.quizTitle)}</h1>
      <div class="header-icons">
        <button class="icon-btn" onclick="toggleMute()">${state.isMuted ? '🔇' : '🔊'}</button>
        <button class="icon-btn" onclick="toggleDarkMode()">${state.dark ? "☀️" : "🌙"}</button>
      </div>
    </div>
    <p>Number of Questions in the Main Bank: <b>${state.mainQuestionBank.length} Questions</b></p>
    <div class="main-menu">
      <div class="menu-button" onclick="setView('study_setup')">📖<br>Study Question</div>
      <div class="menu-button" onclick="setView('test_setup')">📝<br>Test Question</div>
      <div class="menu-button" onclick="setView('sixty_setup')">⏱️<br>60/60 Test</div>
      <div class="menu-button" onclick="setView('timelimit_setup')">⏳<br>Time Limit Test</div>
      <div class="menu-button" onclick="setView('memories_list')">🧠<br>Memories List</div>
      <div class="menu-button" onclick="setView('memories_setup')">🎯<br>Memories Test</div>
      <div class="menu-button" onclick="setView('view_bank')">🏦<br>View Question Bank</div>
      <div class="menu-button" onclick="setView('instruction')">ℹ️<br>Instruction</div>
    </div>
    <div class="notes-section">
      <p><b>Note:</b> For safety reasons (Malware, Malicious Links), please ONLY download the Quiz from an official source.</p>
      <p><b>Note:</b> For iOS, you may need to download an HTML viewer app, then import this file into it. For PC and Android, you can open this file directly in your browser.</p>
      <p><b>Notice:</b> This Quiz is offline. It doesn't require any Internet connection nor does it connect to a server. It runs entirely within this single file.</p>
    </div>
  `;
}
function renderViewBank(app) {
    app.innerHTML = `
        ${renderHeader("Main Question Bank")}
        <button onclick="addNewQuestion()">Add New Question</button>
        <div class="manage-list" style="margin-top: 20px;">
          ${state.mainQuestionBank.map((q, i) => renderManageQuestion(q, i, true)).join('')}
        </div>
    `;
}
function renderManageQuestion(q, index, isMainBankView) {
    const originalIndex = isMainBankView ? index : state.memoriesList[index];
    const questionData = state.mainQuestionBank[originalIndex];
    if (!questionData) return ''; // Safety check

    return `
    <div class="question-card">
      <div style="display: flex; justify-content: space-between; align-items: flex-start;">
        <div style="font-weight:bold;">Q${originalIndex + 1}: ${escapeHtml(questionData.question)}</div>
        <div class="manage-actions">
          <button onclick="editQuestion(${originalIndex})">Edit</button>
          <button class="btn-danger" onclick="${isMainBankView ? `deleteQuestion(${originalIndex})` : `deleteFromMemory(${index})`}">Delete</button>
        </div>
      </div>
      ${questionData.img ? `<img src="${questionData.img}" class="question-img">` : ""}
      <ol type="A" style="margin:12px 0 0 20px; padding-left: 0;">
        ${questionData.responses.map((r, j) => `
          <li style="padding: 4px 0; ${j === questionData.correct ? 'font-weight:600; color:var(--correct);' : ''}">
            ${escapeHtml(r)}
          </li>`).join('')}
      </ol>
    </div>
  `;
}
function renderMemoriesList(app) {
    let content = `
        ${renderHeader("Memories List")}
        <div class="setup-form">
            <div class="form-group">
                <label for="add-mem-input">Add questions from Main Bank by number (e.g., "45, 52, 60-70"):</label>
                <input type="text" id="add-mem-input" placeholder="Enter numbers or ranges...">
            </div>
            <button onclick="addQuestionsToMemory()">Add to List</button>
        </div>
        <div class="manage-list" style="margin-top: 20px;">
    `;
    if (state.memoriesList.length === 0) {
        content += `<p>Your memories list is empty. Incorrectly answered questions from tests will appear here.</p>`;
    } else {
        content += state.memoriesList.map((qIndex, i) => renderManageQuestion(null, i, false)).join('');
    }
    content += `</div>`;
    app.innerHTML = content;
}
function renderRangeSetup(app, mode) {
    app.innerHTML = `
        ${renderHeader(mode === 'study' ? 'Study Question Setup' : 'Test Question Setup')}
        <div class="setup-form">
            <p>Select the questions you want to practice.</p>
            <div id="range-container">
                <div class="form-group range-input">
                    <label>From</label>
                    <input type="number" class="range-from" min="1" max="${state.mainQuestionBank.length}" placeholder="1">
                    <label>To</label>
                    <input type="number" class="range-to" min="1" max="${state.mainQuestionBank.length}" placeholder="${state.mainQuestionBank.length}">
                </div>
            </div>
            <button onclick="startTestFromRange('${mode}')">Start ${mode === 'study' ? 'Study' : 'Test'}</button>
            <button class="btn-secondary" onclick="startTestFromRange('${mode}', true)">${mode === 'study' ? 'Study' : 'Test'} Whole Bank</button>
        </div>
    `;
}
function renderFullTest(app) {
    const { mode } = state.currentTestConfig;
    app.innerHTML = `
        ${renderHeader(mode === 'study' ? 'Study Session' : 'Test Session')}
        <div id="full-test-container">
            ${state.testQuestions.map((q, i) => renderFullTestQuestion(q, i, mode)).join('')}
        </div>
        <button onclick="finishAttempt()" style="margin-top: 20px; width: 100%; padding: 15px; font-size: 1.2em;">Finish Attempt</button>
    `;
}
function renderFullTestQuestion(q, index, mode) {
    const answer = state.answers[index];
    const isAnswered = answer !== undefined;

    return `
    <div class="question-card" id="q-card-${index}">
      <h3 style="font-weight:bold;">
        ${mode === 'study' ? `Q${q.originalIndex + 1}: ` : ''}${escapeHtml(q.question)}
      </h3>
      ${q.img ? `<img src="${q.img}" class="question-img">` : ''}
      <div class="responses">
        ${q.shuffledResponses.map((r, j) => {
            const isCorrect = q.shuffledMap[j] === q.correct;
            const isSelected = j === answer;
            let cls = 'response-box';
            if (isAnswered) {
                if (isSelected && isCorrect) cls += ' correct';
                else if (isSelected && !isCorrect) cls += ' wrong';
                else if (isCorrect) cls += ' correct'; // Show correct one if user was wrong
            }
            return `
            <div class="${cls}" onclick="handleImmediateFeedback(${index}, ${j})">
              <span class="response-prefix">${String.fromCharCode(65 + j)})</span>
              <span>${escapeHtml(r)}</span>
            </div>`;
        }).join('')}
      </div>
    </div>
    `;
}
function renderSixtySetup(app) {
    app.innerHTML = `
        ${renderHeader("60/60 Test Setup")}
        <div class="setup-form">
            <div class="form-group">
                <label for="difficulty">Select Difficulty:</label>
                <select id="difficulty" style="width:100%; padding: 10px; font-size: 1em;">
                    <option value="60">Normal (60s / Q)</option>
                    <option value="45">Lag lag lag (45s / Q)</option>
                    <option value="30">Why so slow? (30s / Q)</option>
                    <option value="20">Stuck n Suprise (20s / Q)</option>
                    <option value="15">I will send to Jesus (15s / Q)</option>
                    <option value="10">Asian diff (10s / Q)</option>
                </select>
            </div>
            <button onclick="startPagedTest('sixty')" ${state.mainQuestionBank.length < 60 ? 'disabled' : ''}>
              Start 60/60 Test
            </button>
            ${state.mainQuestionBank.length < 60 ? `<p style="color:var(--error);">You need at least 60 questions in the main bank to start this mode.</p>` : ''}
        </div>
    `;
}
function renderTimeLimitSetup(app) {
    app.innerHTML = `
        ${renderHeader("Time Limit Test Setup")}
        <div class="setup-form">
            <div class="form-group">
                <label>Select Question Range:</label>
                <div class="range-input">
                    <label>From</label>
                    <input type="number" id="range-from" min="1" max="${state.mainQuestionBank.length}" value="1">
                    <label>To</label>
                    <input type="number" id="range-to" min="1" max="${state.mainQuestionBank.length}" value="${state.mainQuestionBank.length}">
                </div>
            </div>
            <div class="form-group">
                <label for="time-limit">Time per question (seconds):</label>
                <input type="number" id="time-limit" min="5" value="30">
            </div>
            <button onclick="startPagedTest('timelimit')">Start Time Limit Test</button>
            <button class="btn-secondary" onclick="startPagedTest('timelimit', true)">Test Whole Bank</button>
        </div>
    `;
}
function renderMemoriesSetup(app) {
    app.innerHTML = `
        ${renderHeader("Memories Test Setup")}
        <div class="setup-form">
            <div class="form-group">
                <label>Test Mode:</label>
                <select id="mem-test-mode" style="width:100%; padding: 10px; font-size: 1em;">
                    <option value="memory_only">Only Questions from Memories List (${state.memoriesList.length} questions)</option>
                    <option value="memory_plus">Memories List + Random from Main Bank</option>
                </select>
            </div>
            <div class="form-group" id="extra-questions-group" style="display:none;">
                <label for="extra-questions">Number of random questions to add from Main Bank:</label>
                <input type="number" id="extra-questions" min="1" value="10" max="${state.mainQuestionBank.length - state.memoriesList.length}">
            </div>
            <button onclick="startPagedTest('memory')" ${state.memoriesList.length === 0 ? 'disabled' : ''}>Start Memories Test</button>
             ${state.memoriesList.length === 0 ? `<p style="color:var(--error);">Your memories list is empty. Add questions to start.</p>` : ''}
        </div>
    `;
    // Add event listener to show/hide extra questions input
    setTimeout(() => {
        const select = document.getElementById('mem-test-mode');
        const extraGroup = document.getElementById('extra-questions-group');
        if (select) {
            select.addEventListener('change', (e) => {
                extraGroup.style.display = e.target.value === 'memory_plus' ? 'block' : 'none';
            });
        }
    }, 0);
}
function renderPagedTest(app) {
    clearTimeout(state.timerId);
    const q = state.testQuestions[state.idx];
    if (!q) {
        finishAttempt();
        return;
    }
    const answered = state.answers[state.idx] !== undefined;
    const { timePerQuestion, total, timeLeft } = state.currentTestConfig;

    app.innerHTML = `
        ${renderHeader(state.currentTestConfig.title)}
        <div class="progress-bar-wrap"><div class="progress-bar" style="width:${((state.idx) / total) * 100}%"></div></div>
        <div style="display: flex; justify-content: space-between; margin-bottom: 10px; font-weight: 500;">
            <span>Question ${state.idx + 1} of ${total}</span>
            ${timePerQuestion ? `<span>Time left: <b>${timeLeft}s</b></span>` : ''}
        </div>
        <div class="question-card">
            <h3 style="font-weight:bold;">${escapeHtml(q.question)}</h3>
            ${q.img ? `<img src="${q.img}" class="question-img">` : ''}
            <div class="responses">
                ${q.shuffledResponses.map((r, j) => {
                    const isCorrect = q.shuffledMap[j] === q.correct;
                    const isSelected = state.answers[state.idx] === j;
                    let cls = 'response-box';
                    if (answered) {
                        if (isSelected && isCorrect) cls += ' correct';
                        else if (isSelected && !isCorrect) cls += ' wrong';
                        else if (isCorrect) cls += ' correct';
                    }
                    return `
                    <div class="${cls}" onclick="handlePagedAnswer(${j})">
                        <span class="response-prefix">${String.fromCharCode(65 + j)})</span>
                        <span>${escapeHtml(r)}</span>
                    </div>`;
                }).join('')}
            </div>
        </div>
        ${answered ? `<button onclick="nextPagedQuestion()" style="width:100%; padding: 15px; font-size: 1.2em;">${state.idx + 1 === total ? 'Finish' : 'Next Question'}</button>` : ''}
    `;

    if (timePerQuestion && !answered) {
        state.timerId = setTimeout(pagedTimerTick, 1000);
    }
}
function renderResults(app) {
    const { correctCount, total, wrongAnswers } = state.currentTestConfig.results;
    const score = total > 0 ? Math.round((correctCount / total) * 100) : 0;
    app.innerHTML = `
        ${renderHeader("Test Results")}
        <div class="score-bar">${correctCount} / ${total} (${score}%)</div>
        <div class="score-remark">${getScoreRemark(score)}</div>
        <div class="progress-bar-wrap" style="margin-top: 20px;"><div class="progress-bar" style="width:${score}%"></div></div>
        <div style="margin-top: 30px; text-align: center;">
            <button onclick="retryTest()">Try Again</button>
            <button class="btn-secondary" onclick="setView('menu')">Back to Main Menu</button>
        </div>
        <div style="margin-top: 30px;">
            <h3 style="border-bottom: 2px solid var(--border); padding-bottom: 10px;">
                Questions Answered Incorrectly (${wrongAnswers.length})
            </h3>
            ${wrongAnswers.length === 0
                ? `<p style="color: var(--correct); font-weight: 600;">Congratulations! You answered all questions correctly! 🎉</p>`
                : wrongAnswers.map(item => renderWrongReview(item.q)).join('')
            }
        </div>
    `;
}

function renderWrongReview(q) {
    const questionData = state.mainQuestionBank[q.originalIndex];
    if (!questionData) return ''; // Should not happen

    return `
    <div class="question-card">
        <div style="font-weight:600;">Q${q.originalIndex + 1}: ${escapeHtml(questionData.question)}</div>
        ${questionData.img ? `<img src="${questionData.img}" class="question-img">`:''}
        <div class="responses">
            ${questionData.responses.map((r,j)=>{
                const isCorrect = (j === questionData.correct);
                let cls = "response-box";
                if(isCorrect) {
                    cls += " correct";
                }
                return `<div class="${cls}" style="cursor:default;">
                            <span class="response-prefix">${String.fromCharCode(65+j)})</span>
                            <span>${escapeHtml(r)}</span>
                        </div>`;
            }).join('')}
        </div>
    </div>`;
}

function renderInstruction(app) {
    app.innerHTML = `
    ${renderHeader("Instructions")}
    <div class="instruction-page">
      <p>Welcome to the Multiple Choice Question Preparation tool! Here's how to use the different features:</p>

      <h3>📖 Study Question</h3>
      <p>This mode is for practice. You can choose to study all questions or a specific range. Your answers are checked immediately. Incorrectly answered questions are added to your "Memories List".</p>

      <h3>📝 Test Question</h3>
      <p>This mode simulates a real test. Questions and answer options are randomized. You won't see if you're right or wrong until you finish. Your score and incorrect answers are shown at the end.</p>

      <h3>⏱️ 60/60 Test</h3>
      <p>A fast-paced challenge where you answer 60 random questions from the bank. Each question has a time limit based on the difficulty you select. Great for testing your speed and accuracy under pressure.</p>

      <h3>⏳ Time Limit Test</h3>
      <p>Similar to the "Test Question" mode, but you can set a custom time limit for each question. This is perfect for practicing under specific time constraints.</p>

      <h3>🧠 Memories List</h3>
      <p>This is your personal list of challenging questions. Any question you get wrong in a test is automatically added here. You can also add questions manually. Use the "Memories Test" to focus on these questions.</p>

      <h3>🎯 Memories Test</h3>
      <p>A targeted test to help you conquer your difficult questions. You can choose to test only the questions in your "Memories List", or mix them with a set number of random questions from the main bank.</p>

      <h3>🏦 View Question Bank</h3>
      <p>Here you can see all the questions available in the quiz. You can add new questions, edit existing ones, or delete them. This is the master list for all tests.</p>
    </div>
  `;
}

function renderEdit(app) {
    const q = state.editQ;
    if (!q) {
        setView('view_bank');
        return;
    }
    app.innerHTML = `
        ${renderHeader(state.editIdx === -1 ? 'Add New Question' : `Edit Question ${state.editIdx + 1}`)}
        <div class="setup-form">
            <div class="form-group">
                <label for="edit-q-text">Question Text (use &lt;br&gt; for line breaks):</label>
                <textarea id="edit-q-text" rows="3">${escapeHtml(q.question)}</textarea>
            </div>
            <div class="form-group">
                <label for="edit-q-img">Image URL (optional):</label>
                <input type="text" id="edit-q-img" value="${q.img || ''}">
            </div>
            <div id="responses-editor">
                ${q.responses.map((r, i) => `
                    <div class="form-group">
                        <label>Response ${i + 1}:</label>
                        <input type="text" class="response-input" value="${escapeHtml(r)}">
                    </div>
                `).join('')}
            </div>
            <div class="form-group">
                <label for="edit-q-correct">Correct Answer (1-${q.responses.length}):</label>
                <input type="number" id="edit-q-correct" min="1" max="${q.responses.length}" value="${q.correct + 1}">
            </div>
            <button onclick="saveQuestion()">Save Question</button>
            <button class="btn-secondary" onclick="setView('view_bank')">Cancel</button>
        </div>
    `;
}


// --- Event Handlers & Logic ---
function setView(view) {
    if (view === 'view_bank') {
        // Clear local storage except for memories list
        const memories = localStorage.getItem(MEMORY_LIST_KEY);
        localStorage.clear();
        if (memories) {
            localStorage.setItem(MEMORY_LIST_KEY, memories);
        }
    }
    state.view = view;
    render();
}

function updateTitle(element) {
    state.quizTitle = element.innerText;
}

function addNewQuestion() {
    state.editIdx = -1;
    state.editQ = {
        question: "",
        img: "",
        responses: ["", "", "", ""],
        correct: 0
    };
    setView('edit_question');
}

function editQuestion(index) {
    state.editIdx = index;
    // Deep copy the question to avoid modifying the original during editing
    state.editQ = JSON.parse(JSON.stringify(state.mainQuestionBank[index]));
    setView('edit_question');
}

function deleteQuestion(index) {
    if (confirm(`Are you sure you want to delete Question ${index + 1}?`)) {
        state.mainQuestionBank.splice(index, 1);
        // Also remove from memories list if it's there
        state.memoriesList = state.memoriesList.filter(memIndex => memIndex !== index);
        state.memoriesList = state.memoriesList.map(memIndex => memIndex > index ? memIndex - 1 : memIndex);
        saveData();
        render();
    }
}

function saveQuestion() {
    const questionText = document.getElementById('edit-q-text').value;
    const imgUrl = document.getElementById('edit-q-img').value;
    const correct = parseInt(document.getElementById('edit-q-correct').value, 10) - 1;
    const responses = Array.from(document.querySelectorAll('.response-input')).map(input => input.value);

    if (!questionText || responses.some(r => !r) || isNaN(correct) || correct < 0 || correct >= responses.length) {
        alert("Please fill out all fields correctly.");
        return;
    }

    const newQuestion = {
        question: questionText,
        img: imgUrl,
        responses: responses,
        correct: correct
    };

    if (state.editIdx === -1) { // Adding new question
        state.mainQuestionBank.push(newQuestion);
    } else { // Editing existing question
        state.mainQuestionBank[state.editIdx] = newQuestion;
    }
    saveData();
    setView('view_bank');
}


function addQuestionsToMemory() {
    const input = document.getElementById('add-mem-input').value;
    if (!input) return;

    const numbersToAdd = new Set();
    const parts = input.split(',');

    parts.forEach(part => {
        part = part.trim();
        if (part.includes('-')) {
            const [start, end] = part.split('-').map(n => parseInt(n.trim(), 10));
            if (!isNaN(start) && !isNaN(end) && start <= end) {
                for (let i = start; i <= end; i++) {
                    if (i >= 1 && i <= state.mainQuestionBank.length) {
                        numbersToAdd.add(i - 1);
                    }
                }
            }
        } else {
            const num = parseInt(part, 10);
            if (!isNaN(num) && num >= 1 && num <= state.mainQuestionBank.length) {
                numbersToAdd.add(num - 1);
            }
        }
    });

    const currentMemorySet = new Set(state.memoriesList);
    numbersToAdd.forEach(num => currentMemorySet.add(num));
    state.memoriesList = Array.from(currentMemorySet).sort((a, b) => a - b);

    saveData();
    render();
}

function deleteFromMemory(index) {
     if (confirm(`Are you sure you want to delete this question from your Memories List?`)) {
        state.memoriesList.splice(index, 1);
        saveData();
        render();
    }
}

function startTestFromRange(mode, wholeBank = false) {
    let from = 1, to = state.mainQuestionBank.length;
    if (!wholeBank) {
        from = parseInt(document.querySelector('.range-from').value || 1, 10);
        to = parseInt(document.querySelector('.range-to').value || state.mainQuestionBank.length, 10);
    }

    if (from < 1 || to > state.mainQuestionBank.length || from > to) {
        alert("Invalid range selected.");
        return;
    }

    let questionIndices = [];
    for (let i = from - 1; i < to; i++) {
        questionIndices.push(i);
    }

    let testQuestions = questionIndices.map(originalIndex => {
        const q = state.mainQuestionBank[originalIndex];
        return { ...q, originalIndex };
    });

    if (mode === 'test') {
        testQuestions = shuffle(testQuestions);
    }

    state.testQuestions = testQuestions.map(q => {
        const shuffledResponses = shuffle(q.responses);
        const shuffledMap = shuffledResponses.map(r => q.responses.indexOf(r));
        return { ...q, shuffledResponses, shuffledMap };
    });

    state.answers = new Array(state.testQuestions.length);
    state.currentTestConfig = { mode, from, to, wholeBank };
    setView(mode === 'study' ? 'study_test' : 'test_test');
}


function handleImmediateFeedback(questionIndex, responseIndex) {
    if (state.answers[questionIndex] !== undefined) return; // Already answered

    state.answers[questionIndex] = responseIndex;
    render(); // Re-render to show feedback
}

function finishAttempt() {
    let correctCount = 0;
    const wrongAnswers = [];
    const newMemoryItems = new Set(state.memoriesList);

    state.testQuestions.forEach((q, i) => {
        const selectedResponseIndex = state.answers[i];
        if(selectedResponseIndex === undefined) {
             wrongAnswers.push({ q });
             newMemoryItems.add(q.originalIndex);
             return;
        }

        const originalResponseIndex = q.shuffledMap[selectedResponseIndex];
        const isCorrect = originalResponseIndex === q.correct;

        if (isCorrect) {
            correctCount++;
        } else {
            wrongAnswers.push({ q });
            newMemoryItems.add(q.originalIndex);
        }
    });

    state.memoriesList = Array.from(newMemoryItems).sort((a, b) => a - b);
    saveData();

    state.currentTestConfig.results = {
        correctCount,
        total: state.testQuestions.length,
        wrongAnswers
    };

    setView('results');
}

function retryTest() {
    const { mode, wholeBank, from, to, timePerQuestion } = state.currentTestConfig;
    if (mode === 'study' || mode === 'test') {
        startTestFromRange(mode, wholeBank);
    } else if (mode === 'sixty' || mode === 'timelimit' || mode === 'memory') {
        startPagedTest(mode, wholeBank);
    }
}
function startPagedTest(mode, wholeBank = false) {
    let questions = [];
    let config = { mode };

    if (mode === 'sixty') {
        const time = parseInt(document.getElementById('difficulty').value, 10);
        questions = shuffle(state.mainQuestionBank).slice(0, 60).map((q, i) => ({...q, originalIndex: state.mainQuestionBank.indexOf(q)}));
        config.title = "60/60 Test";
        config.timePerQuestion = time;
    } else if (mode === 'timelimit') {
        const time = parseInt(document.getElementById('time-limit').value, 10);
        let from = 1, to = state.mainQuestionBank.length;
        if (!wholeBank) {
            from = parseInt(document.getElementById('range-from').value, 10);
            to = parseInt(document.getElementById('range-to').value, 10);
        }
        let indices = [];
        for (let i = from - 1; i < to; i++) indices.push(i);
        questions = shuffle(indices).map(i => ({...state.mainQuestionBank[i], originalIndex: i}));
        config.title = "Time Limit Test";
        config.timePerQuestion = time;
        config.from = from;
        config.to = to;
        config.wholeBank = wholeBank;
    } else if (mode === 'memory') {
        const testMode = document.getElementById('mem-test-mode').value;
        let memQuestions = state.memoriesList.map(i => ({...state.mainQuestionBank[i], originalIndex: i}));

        if (testMode === 'memory_plus') {
            const extraCount = parseInt(document.getElementById('extra-questions').value, 10);
            const bankIndices = state.mainQuestionBank.map((_,i) => i);
            const nonMemoryIndices = bankIndices.filter(i => !state.memoriesList.includes(i));
            const extraIndices = shuffle(nonMemoryIndices).slice(0, extraCount);
            const extraQuestions = extraIndices.map(i => ({...state.mainQuestionBank[i], originalIndex: i}));
            memQuestions = memQuestions.concat(extraQuestions);
        }
        questions = shuffle(memQuestions);
        config.title = "Memories Test";
    }

    state.testQuestions = questions.map(q => {
        const shuffledResponses = shuffle(q.responses);
        const shuffledMap = shuffledResponses.map(r => q.responses.indexOf(r));
        return { ...q, shuffledResponses, shuffledMap };
    });

    state.answers = new Array(state.testQuestions.length);
    state.idx = 0;
    config.total = state.testQuestions.length;
    if (config.timePerQuestion) {
        config.timeLeft = config.timePerQuestion;
    }
    state.currentTestConfig = config;
    setView('paged_test');
}


function handlePagedAnswer(responseIndex) {
    if (state.answers[state.idx] !== undefined) return;
    state.answers[state.idx] = responseIndex;
    clearTimeout(state.timerId);
    render();
}

function nextPagedQuestion() {
    if (state.idx < state.testQuestions.length - 1) {
        state.idx++;
        if (state.currentTestConfig.timePerQuestion) {
            state.currentTestConfig.timeLeft = state.currentTestConfig.timePerQuestion;
        }
        render();
    } else {
        finishAttempt();
    }
}

function pagedTimerTick() {
    state.currentTestConfig.timeLeft--;
    if (state.currentTestConfig.timeLeft <= 0) {
        state.answers[state.idx] = -1; // Mark as incorrect (timeout)
        nextPagedQuestion();
    } else {
        render();
    }
}

// --- Initial Load ---
window.onload = () => {
  loadData();
  setupAudio();
  render();
};
</script>
</body>
</html>